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Summary
In recent decades,  chronic diseases have reached epidemic proportions in  the indus-
trialised world.  A  physically  inactive lifestyle has been  identified as a  major  factor 
causing maladaptations leading  to coronary  heart  disease,  stroke,  hypertension, type 
2  diabetes, osteoporosis, breast  cancer, and colon cancer.  Regular  physical activity 
prevents the development  of obesity  and induces a  multitude of favourable adapta-
tions within skeletal muscle and the cardio-respiratory  system, which  have positive 
outcomes for  both  the prevention  and treatment  of metabolic  diseases. Specifically, 
high  aerobic function  is related to physical activity  whereas low  aerobic  function  is 
related to physical  inactivity  and various metabolic  diseases. In  order to gain a  better 
understanding  of the mechanisms underlying  aerobic function  and skeletal  muscle 
plasticity  it  is fundamental  to identify  which  specific exercise stimuli  leads to what 
molecular  response, and how  this molecular  response relates to the structural,  con-
tractile, and metabolic  adaptation.  Thus,  the present  thesis was aimed at providing 
new  insights into the mechanisms underlying aerobic function and skeletal  muscle 
plasticity  by  using  an  integrative approach  including  cell  culture, rodent, and human 
models.
In  a  first  study,  in order to shed light  upon  the relationship of aerobic  function  and 
type 1  diabetes,  we investigated factors that  may  limit  oxidative capacity  and aerobic 
exercise performance in  young  untrained women  with  type 1  diabetes. Calf muscle 
oxidative capacity  was not different  between untrained women  with  type 1  diabetes 
and healthy  women of similar  age and activity  levels.  Notably,  HbA1c was negatively 
correlated with  mitochondrial capacity  in  women  with  type 1  diabetes.  Although 
HbA1c was negatively  correlated with  cardiac output  in  women  with  type 1  diabetes, 
maximal oxygen consumption, cardiac output, endurance capacity, skeletal muscle 
oxidative enzyme activity,  and capillary-to-fibre ratio were not  reduced in women 
with  type 1  diabetes compared to healthy  women.  These results indicate  that  oxida-
tive capacity  depends on HbA1c in  untrained women  with  type 1  diabetes but  aerobic 
function is not  reduced relative to untrained healthy  women. Thus, it is important to 
accurately  control glycaemic  status in  future studies investigating  the aerobic  func-
tion in patients with type 1 diabetes.
In  a  second study,  we aimed at  establishing  a cell  culture model to closely  recapitu-
late the plastic  changes in gene expression  as observed in  aerobically  trained skeletal 
muscles of mice.  In electrically  stimulated C2C12  mouse muscle cells the transcrip-
tional adaptations were almost  identical to those in  endurance trained skeletal  mus-
cles of mice, but  differed from  the acute effects of exercise on muscle gene expres-
sion. In  addition,  significant alterations in the expression  of myofibrillar proteins 
indicated that this in vitro  exercise model  could be used to modulate the fibre-type 
of muscle cells in  culture. Our  data  thus describe an  experimental cell  culture model 
for  the study  of at least some of the transcriptional aspects of skeletal muscle adap-
tation to physical activity.
Typically,  aerobic  function can  be improved by  repeated endurance exercise  but  not 
by  resistance exercise.  To overcome the specificity  of this adaptive response we 
aimed in  a  third study  at  designing  a  new  resistance exercise model with  superim-
posed stimuli to induce endurance type adaptations and to test  its effectiveness in 
humans. Indeed, 5  weeks of whole-body  vibration  training with  superimposed heavy 
resistance exercise and sustained vascular  occlusion  (VRO) increased capillary-to-
fibre ratio, skeletal muscle oxidative enzyme activity,  myosin  heavy  chain  type 1  fibre 
proportion,  and endurance capacity.  In  a  fourth  study, we analysed the molecular 
bases underlying these adaptations. A  single bout  of VRO increased the expression 
of vascular  endothelial  growth factor (VEGF) mRNA through  reactive oxygen  species 
(ROS)-activated peroxisome proliferator-activated receptor γ  coactivator  1α (PGC-
1α) probably  in a  hypoxia-inducible factor  1α (HIF-1α) independent  manner.  In  con-
clusion,  modified high-intensity  resistance exercise activates gene programmes typi-
cally linked to endurance exercise.
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Zusammenfassung
In den letzten  Jahrzehnten  haben chronische Krankheiten  in der industrialisierten 
Welt epidemieartig  zugenommen. Ein  körperlich  inaktiver  Lebensstil gilt als Haupt-
ursache für viele verschiedene Krankheiten  wie  koronare Herzkrankheit,  Schlagan-
fall, Bluthochdruck, Typ 2  Diabetes,  Osteoporose, Brust- und Darmkrebs.  Regelmäs-
sige körperliche Aktivität  kann  die Entstehung von  Fettleibigkeit  verhindern und zu 
vielen Anpassungen in  der Skelettmuskulatur  und im  Herzkreislaufsystem  führen 
und dadurch  Stoffwechselerkrankungen  entgegenwirken. Insbesondere hängt  eine 
gute aerobe Muskelfunktion  mit  körperlicher  Aktivität  zusammen, währenddem  ei-
ne verminderte aerobe Muskelfunktion mit körperlicher  Inaktivität  und vielen 
Stoffwechselerkrankungen  in  Zusammenhang  gebracht wird.  Um  ein  besseres 
Verständnis der Mechanismen  der  aeroben  Muskelfunktion  und -plastizität zu  er-
halten,  ist  es notwendig zu  verstehen,  welche spezifischen  Trainingsreize zu  welcher 
molekularen  Antwort  führen und welche molekulare Antworten welche strukturel-
len,  kontraktilen  und metabolischen Adaptationen verursachen. Aus diesem  Grund 
bestand das Ziel  der  vorliegenden  Arbeit  darin, neue Erkenntnisse über  die aerobe 
Muskelfunktion  und -plastizität  zu  erlangen. Zu  diesem  Zweck haben  wir in  unseren 
Studien  einen  integrativen  Ansatz gewählt  und dabei Zellkultur-,  Nagetier- und 
Humanmodelle angewendet.
In  der  ersten Studie  untersuchten  wir den Zusammenhang  zwischen  aerober  Mus-
kelfunktion  und Typ 1  Diabetes.  Wir  haben  Faktoren, welche die oxidative Kapazität 
und aerobe Leistungsfähigkeit  determinieren,  in  untrainierten jungen Frauen  mit 
Typ 1  Diabetes gemessen  und mit gesunden  untrainierten  Frauen im  gleichen  Alter 
verglichen. Die oxidative Kapazität  im  Unterschenkelmuskel hat  sich zwischen un-
trainierten jungen Frauen mit Typ 1 Diabetes und gesunden untrainierten Frauen im  
gleichen  Alter  nicht unterschieden.  Bemerkenswert  ist, dass bei  den  Typ 1  Diabetike-
rinnen  das HbA1c  negativ  mit der  mitochondrialen  Kapazität  korrelierte.  Obwohl bei 
den  Typ 1  Diabetikerinnen das HbA1c auch  mit  dem  Herzminutenvolumen  negativ 
korrelierte, waren  die maximale Sauerstoffaufnahme, Herzminutenvolumen, Aus-
dauerleistungsfähigkeit,  Aktivität von  oxidativen  Enzymen in  der Skelettmuskulatur 
und das Verhältnis der  Kapillaren  zu  den  Skelettmuskelfasern, im  Vergleich  mit 
gleichaltrigen  gesunden Frauen,  nicht  vermindert. Diese Ergebnisse zeigen  auf, dass 
bei untrainierten  Frauen  mit Typ 1  Diabetes die oxidative Kapazität  vom  HbA1c  ab-
hängig ist, die  aerobe Muskelfunktion  verglichen  mit gesunden  untrainierten  Frauen 
aber  nicht  vermindert  ist.  Daher  ist  es wichtig,  in  zukünftigen  Studien  das HbA1c 
sorgfältig zu kontrollieren, wenn man die aerobe Muskelfunktion untersuchen will.
In  einer  zweiten  Studie entwickelten  wir  ein  Zellkulturmodell,  in  welchem  wir  die 
gleichen  Genexpressionsveränderungen  beobachten  konnten,  wie in  Skelettmuskeln 
von ausdauertrainierten  Mäusen.  In  elektrisch  stimulierten  C2C12  Mausmuskelzel-
len waren  die transkriptionellen  Adaptationen  beinahe identisch  mit  denen  in  Ske-
lettmuskeln  von  ausdauertrainierten  Mäusen. Sie unterschieden sich  aber  von  den 
akuten  transkriptionellen  Antworten  in Skelettmuskeln  von  Mäusen.  Zudem  zeigten 
sich  signifikante Veränderungen  in der  Expression  von  myofibrillären Proteinen. 
Unsere Studienergebnisse zeigen,  dass wir  dieses Zellkulturmodell  dafür  verwenden 
können,  um  transkriptionelle Veränderungen im  Skelettmuskel  nach  körperlicher 
Aktivität und Veränderungen des Skelettmuskelfasertypus zu untersuchen. 
Üblicherweise kann  die aerobe Muskelfunktion  mit  regelmässigem  Ausdauertrai-
ning nicht  aber  mit  Krafttraining  verbessert  werden.  Um  diese spezifischen  Anpas-
sungen zu  umgehen, haben wir  in  einer  dritten  Studie ein  neuartiges Trainingsmo-
dell  entwickelt.  Unser Ziel war es,  mit  einem  modifizierten  Krafttraining  Adaptionen 
hervorzurufen,  welche normalerweise mit  Ausdauertraining einhergehen. Das modi-
fizierte  Krafttraining  bestand aus einer  Kombination  aus intensivem  Vibrations- und 
Krafttraining mit gleichzeitig unterbundenem  Blutfluss zu  und aus den  Beinen. Wir 
konnten  zeigen,  dass fünf Wochen  modifiziertes Krafttraining  zu  einem  erhöhten 
Verhältnis der  Kapillaren zu  den Skelettmuskelfasern  führte  und dies mit  einer  er-
höhten  Aktivität  von  oxidativen  Enzymen  in  den  Skelettmuskeln  einherging. Zudem 
nahm der Anteil der Typ I Muskelfasern und die Ausdauerleistungsfähigkeit zu. 
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In  der  vierten  Studie untersuchten  wir  die molekularen  Mechanismen, welche zu 
den  beschriebenen  Adaptationen  führten.  Ein  einzelnes modifiziertes Krafttraining 
erhöhte die mRNA Expression von  “vascular  endothelial growth  factor”  (VEGF) und 
“peroxisome proliferator-activated receptor γ  coactivator  1α”  (PGC-1α). Möglicher-
weise aktivierten  “reactive oxygen  species”  (ROS)  flussabwärts PGC-1α, welches wei-
ter  VEGF auf eine “hypoxia-inducible factor 1α”  (HIF-1α) unabhängige Weise indu-
zierte.  Unsere Studienergebnisse belegen, dass ein modifiziertes hochintensives 
Krafttraining Genprogramme induzieren  kann,  welche üblicherweise nach  Ausdau-
ertraining beobachtet werden.
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Chapter 1
Introduction
In recent  decades, chronic diseases have reached epidemic proportions in the 
industrialised world (Booth  et al.  2002). A  physically  inactive lifestyle has been 
identified as a major  factor  causing maladaptations leading  to chronic diseases 
(Booth  et  al.  2008,  Booth  and Lees 2007, Centers for  Disease Control and 
Prevention  2006).  Physical inactivity  increases the risk  of coronary  heart disease, 
stroke, hypertension,  type 2  diabetes, osteoporosis,  breast  cancer,  and colon  cancer 
by  between  30% and 60%  (Booth  and Laye 2009, Katzmarzyk and Janssen 2004, 
Fig. 1.1). Regular  physical activity  (together  with  a  balanced energy  intake) prevents 
the development of obesity  and induces a multitude of favourable adaptations within 
skeletal  muscle and the cardio-respiratory  system, which  have positive outcomes for 
both  the prevention  and treatment of metabolic  diseases (Hawley  and Holloszy 
2009).  Booth  and Laye (2009) recently  pointed out that in  order  to prove causality 
between  physical inactivity  and chronic  diseases it is necessary  to understand the 
underlying molecular  pathways. However,  the mechanisms that mediate the 
therapeutic  effects of exercise and the pathological changes elicited by  a  sedentary 
lifestyle remain  enigmatic and have to be fully  elucidated (Handschin  and 
Spiegelman 2008).
Skeletal muscle plasticity.  The human  body  contains about 660 different  skeletal 
muscles accounting for  about  45% of body  mass (Brooks et al. 2005). Beside the 
primary  purpose as a  motor  for  locomotion, skeletal  muscle is an  important  tissue 
for whole-body energy metabolism and substrate turnover, and therefore makes a
  
Figure 1.1: Chronic  health  diseases induced upon  decreasing physical  activity  from 
high to low levels (Booth and Laye 2009).
major impact  on  metabolic  health.  Furthermore, skeletal muscle is a  highly 
malleable tissue (Baldwin and Haddad 2002, Flueck  2006, Flueck and Hoppeler 
2003,  Schiaffino et  al. 2007) whose structure and function  can  be changed as a 
consequence of contractile activity, substrate supply, environmental factors such  as 
hypoxia  and thermal  stress,  and ageing  (Flueck and Hoppeler  2003). Skeletal 
muscle plasticity  has been  defined as “the ability  of a given  muscle cell  to alter  1) the 
quantity  (amount) of and/or 2)  the type of protein  (i.e.  phenotype or  isoform) 
comprising its different subcellular components in response to any type of stimulus 
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that  disrupts its normal homeostasis”  (Booth  and Baldwin 1995).  In  detail,  the 
specific stimuli perturb the skeletal  muscle’s homeostasis,  and this signal is in  turn 
mechano-chemically  transduced into a  molecular  and cellular  response (Toigo and 
Boutellier  2006).  As such,  the combination of mechanical  stress,  metabolic  stress, 
and altered calcium  flux  within  skeletal  muscle determines the mechano-chemical 
transduction, based on  the individuals’ genetic background,  age, gender,  and several 
other factors. These molecular  and cellular  responses finally  lead to specific 
structural  and metabolic adaptations that result  in task-specific  functional 
enhancements or  clinical effects (i.e.  adaptational effects) (Fig.  1.2; Toigo and 
Boutellier 2006).
Figure 1.2: Model of the signalling transduction  pathways induced by  specific 
exercise stimuli which  lead to a  structural adaptation with  associated adaptational 
effect  (Toigo and Boutellier  2006). An  exercise stimulus with  specific mechano-
biological  characteristics (a) induces a  specific  signal transduction  pathway  (c) based 
on  the respective response matrix  (b)  which  leads into a quantitative and/or 
qualitative adaptation  (d).  Such  an  adaptation  can  finally  lead to an  adaptational 
effect  (e). Of important note is,  that  there exist  only  a  causal connection between  (c) 
and (d) (red shading).
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m = f(G, Y, S, A, M, T, H, N, I,...)
Genotype (G)
Age (Y)
Gender (S)
Muscular architecture (A)
Muscular subsystem (M)
Muscular anthropometry (T)
Hormonal status (H)
Nutritional status (N)
Immunological status (I)
x1...xi, mechano-biological exercise
stimulus determinants
e = f(x1...xi)
s = f(e, m, ...)
a = f(s)
z = f(a)
a
b
c
d
e
exercise stimulus (e)
signal transduction (s)
adaptation (a)
adaptational effect (z)
response matrix (m)
Skeletal muscle function
Excitation-contraction coupling.  The contraction of the mammalian  skeletal muscle 
is neurally  controlled. The activity  of an efferent α-motor  neuron induces an  action 
potential at  the neuromuscular  junctions. This action  potential  triggers the release of 
Ca2+ from  the sarcoplasmic reticulum  into the cytoplasmic space.  Subsequently,  Ca2+ 
binds to troponin provoking an  ATP-dependent interaction  changes of myosin  and 
actin  in the contractile apparatus (excitation-contraction  coupling) (Huxley  1988). 
This force production  is energy-dependent, thus ATP gets hydrolysed to ADP, 
inorganic phosphate,  and free energy. There are several systems, which  cope with 
the increasing  energy  demand during  the excitation-contraction  coupling.  The first 
system  is composed of high-energy  phosphate transformations involving  the 
coupling of the creatine kinase and adenylate kinase  enzyme systems. Creatine 
phosphate provides a  reserve of phosphate energy  to regenerate ATP and adenylate 
kinase  catalyses the generation of one ATP and one AMP from  two ADPs.  The 
second system  involves the mobilisation  of endogenous glycogen  through  the 
glycolytic  pathway  to regulate the ATP levels independent  of oxidative processes. 
The third system  include the regeneration  of ATP from  ADP through oxidative 
phosphorylation  of reduction  equivalents arising from  the combustion  of 
carbohydrates and/or  fatty  acids.  Glycolysis yields ATP at  high  rates but  is less 
efficient  in  generating  ATP yield per  mole of glucose than  the oxidative 
phosphorylation  process (Booth  and Baldwin 1995,  Brooks et  al. 2005, Flueck  and 
Hoppeler  2003).  During  continued skeletal muscle activity, the balance between 
carbohydrate and fat  metabolism  is controlled by  two factors:  1) by  the intensity  of 
physical  activity  and 2) the supply  of nutrient from  intracellular  (intramyocellular 
lipids,  glycogen) and extracellular  stores (in  liver  and adipose tissue). Extracellular 
substrate delivery  depends on  the capillary  system, which is determined by  the 
conditions for oxygen transfer to skeletal muscle cells (Flueck and Hoppeler 2003). 
Skeletal muscle  fibres.  Skeletal  muscle displays a  remarkable heterogeneity  in  terms 
of fibre type composition. Commonly,  skeletal muscle fibres are distinguished either 
as slow- or  fast-twitch. More specifically, skeletal muscle fibres are subdivided based 
on  the expression of the predominant myosin  heavy  chain  (MYH) isoforms,  and 
hybrid fibre types which express a combination of MYH isoforms (Pette and Staron 
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2000).  Basically,  mammalian skeletal muscles fibres are  classified in  terms of their 
contractile and metabolic  properties.  Human skeletal muscles express the pure fibre 
types MYH-1,  MYH-2A, and MYH-2X, whereas rodent skeletal muscles additionally 
express MYH-2B (Tab. 1.1; Smerdu  et  al.  1994). Skeletal muscles encompass a 
variety  of different fibre types displaying  a continuum  of pure and hybrid fibre types. 
The cycling kinetics of the cross-bridge machinery  within  a muscle fibre is thought 
to be mediated by  the specific activity  of its myosin adenosine  triphosphatase 
(ATPase)  (Caiozzo et  al.  1991). Additional  qualitative differences exist  between fibre 
types with  fibre  type specific isoforms of the essential  and regulatory  myosin  light 
chains, troponin  subunits, tropomyosin,  α-actinin,  and various Ca2+-regulatory 
proteins (e.g.  sarcoplasmic reticulum  Ca2+-ATPase,  calsequestrin, and the α-subunit 
of the dihydropyridine receptor) (Pette and Staron  2000). There are not  only 
qualitative,  but  also quantitative differences between  fibre types such as metabolic 
enzyme activity  levels, e.g. oxidative (cytochrome c oxidase,  succinate dehydro-
genase, NADH-tetrazolium  reductase)  or  glycolytic  (glycogen phos-phorylase) 
enzymes.  However, quantitative differences do not  lead to an  exact  distinction 
between  fibre types, but  rather  encompass a  continuum  with  large overlaps in 
enzyme activity  levels between the different MYH isoforms (Pette and Staron  2000). 
This classification  of different  MYH-isoforms has been  extended to the concept of 
complex,  functional gene groupings within  skeletal muscle  fibres which  adapt 
independently  to environmental  stimuli (Spangenburg  and Booth  2003).  Such  gene 
domains are contractile  protein  isoforms,  mitochondrial volume, myoglobin  levels, 
capillary  density,  and oxidative enzyme capacity. Contractile activity  following 
neural activation  is thought  to induce changes in  common  regulatory  factors within 
the gene domains to modify  the muscle fibre phenotype (Spangenburg  and Booth 
2003).
Exercise.  Exercise has been  defined in dictionaries as follows: “active: bodily 
exertion  for  the sake of restoring  the organs and functions to a  healthy  state or 
keeping  them  healthy”  or  as “regular  or  repeated use of a faculty  or bodily  organ or 
bodily  exertion for  the sake of developing  and maintaining  physical  fitness”  (Booth 
and Thomason  1991).  It has been suggested that these definitions can  be applied to 
human  physical activities and to most  animal models that  mimic human  physical 
activity, involving  repeated body  exertion  invoking  multiple organ  systems (Booth 
and Thomason  1991).  However, Booth  and Thomason  (1991)  pointed out that 
interpretations of exercise experiments with animals and muscle cell cultures have
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Table 1.1: Characteristics of skeletal  muscles in  terms of functional  units of common 
metabolic  and biochemical properties and their  primary  adaptive change (Booth  and 
Baldwin 1995).
The myosin heavy  chains (MYH) listed in  brackets indicate which isoform  the 
primary  MYH is transformed into during adaptations in  response to either increases 
or  decreases in  mechanical activity. The arrowheads listed in  brackets indicates 
either  increases or  decreases in  the relative expression  of a  given property  or enzyme 
system  in  response to increases or  decreases in  mechanical activity  imposed on  that 
specific motor unit.
to be done with  caution,  since these models often  do not  include the entire body  or 
organ  system. Commonly, the term  exercise is used to describe a  wide variety  of 
(sport) activities.  In the traditional view,  it  is broadly  classified as either  endurance, 
resistance (strength),  or  high-intensity.  In order  to classify  different  exercise 
modalities precisely,  two factors have to be considered: 1)  load and 2) time duration. 
Endurance exercise is described as low-load,  long  duration  exercise modality, e.g. 
40-60 min  cycling  at  a  power  corresponding  to ∼65%  peak oxygen  consumption  or 
as 40-60  min  dynamic knee extension  exercise at  a  power  corresponding  to ∼70% of 
2  min  maximal  power.  In  contrast,  resistance exercise is described as high-load, 
short  duration exercise modality,  e.g.  6-12  repetition  with  single or  multiple sets. 
High-intensity  exercise is defined as the ability  to overcome a  relatively  high load in 
a  very  short  time period, e.g.  4  x  4  min  at a power  corresponding  to ∼90-95% peak 
heart rate followed by 3 min of active resting at 70% peak heart rate or 4-6 repeated 
Introduction  6
all-out 30  s Wingate tests separated by  4  min  recovery. When these described 
exercise modalities are repeatedly  performed for  several  weeks, the term  “exercise 
training” is used.
Adaptations of skeletal muscle in response to endurance exercise
Repeated bouts of endurance exercise induce mitochondrial biogenesis,  oxidative 
enzyme activity, and angiogenesis,  leading to a  fatigue-resistant  skeletal  muscle 
phenotype and to an  increased capacity  of skeletal muscle to oxidise fatty  acids and 
carbohydrates (Hood et al.  2006, Holloszy  and Booth  1976,  Holloszy  and Coyle 
1984).  Moreover, endurance exercise has been shown to promote fibre type 
transformation from  MYH-2B/X to MYH-2A (Fitzsimons et  al.  1990).  As a 
consequence of the  adaptive increase in  mitochondrial  mass and oxidative enzyme 
activity, the disturbance in  metabolic  homeostasis during submaximal exercise is 
reduced. This is evidenced by  smaller  decreases in  skeletal muscle ATP,  creatine 
phosphate,  and glycogen,  and smaller  increases in  AMP, inorganic phosphate and 
lactate at a  given  prolonged submaximal skeletal  muscle contractile activity 
(Constable et  al. 1987). Taken  together, these adaptations improve the oxidative 
exercise capacity,  making  it  possible to exercise at  higher  intensities for  longer  time 
periods.
Exercise-induced mitochondrial biogenesis. It  has been  hypothesised that  the 
adaptation  of skeletal muscles following endurance exercise,  results from  cumulative 
effects of transient increases in  mRNA  transcripts encoding specific proteins after 
consecutive exercise sessions (Flueck and Hoppeler  2003, Pilegaard 2000, Williams 
and Neufer  1996). The coordination  of the gene response to endurance exercise is 
complex since it  has been  reported that  a  single bout of endurance exercise in  mice 
changes the expression  of more than 900  genes (Choi et al.  2005). Importantly, 
peroxisome proliferator-activated receptor  γ  coactivator  1α (PGC-1α) has been 
shown to be transiently  increased after  a  single bout of endurance exercise (Baar  et 
al.  2002, Mahoney  et  al.  2005, Norrbom  et al.  2004, Pilegaard et  al. 2003, Terada et 
al.  2002),  and to be elevated at  the basal level after  chronic  endurance exercise 
training (Goto et  al. 2000,  Russell et  al. 2003,  Taylor  et al.  2005). PGC-1α was 
originally  identified as a  coactivator  of peroxisome proliferator-activated receptor  γ 
(PPARγ) transcription factor in brown adipose cells (Puigserver et al. 1998). 
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Subsequent  studies revealed that PGC-1α is also expressed in  liver  and skeletal 
muscle tissue where it coordinates the expression  of both nuclear- and 
mitochondrial-encoded genes in  mitochondrial biogenesis (Puigserver  and 
Spiegelman 2003, Scarpulla  2002).  PGC-1α docks on and coactivates the nuclear 
respiratory  factors 1  and 2α (NRF1  and NRF2α) (Scarpulla  2002,  Wu  et  al. 1999). 
These transcription factors regulate the expression  of nuclear  genes encoding 
mitochondrial proteins and induce the expression  of mitochondrial transcription 
factor  A  (Tfam) (Wu  et  al.  1999). PGC-1α also activates the transcription  factor 
estrogen-related receptor  α (ERRα) (Huss et  al., 2004), which  elicits a  robust 
induction of vascular endothelial  growth  factor  (VEGF) in  cultured muscle cells and 
mouse skeletal muscle  in vivo following hypoxia  and limb ischaemia,  respectively 
(Arany et al. 2008). 
There is ample evidence that  several different  mechanisms are responsible for  the 
endurance exercise-dependent  activation  of PGC-1α,  including activation  of its 
expression  and/or  post-translational modifications (e.g.  phophorylation, lysine 
deacetylation,  and arginine methylation) (Fig. 1.3).  AMP-activated protein  kinase 
(AMPK) is capable of sensing and transducing  changes in cellular  energy  status, and 
activates the expression  of PGC-1α in  an unknown  manner  (Jaeger  et al. 2007,  Lee 
et al. 2006, Terada et  al. 2002).  However,  AMPK is not essential  for  adaptations of 
skeletal  muscle to endurance exercise since it has been  reported that  a  muscle-
specific expression  of a  dominant-negative form  of AMPKα2  fails to block the 
induction of PGC-1α expression  and mitochondrial enzyme activity  (Rockl et  al. 
2008), and genetic  deletion  of functional  AMPK isoforms fails to block exercise-
induced PGC-1α gene expression  in  skeletal muscle (Jorgensen  et al.  2005). 
Mechanical  stress phosphorylates p38 mitogen-activated protein  kinase (p38 
MAPK) and is responsible for an  increased calcium  influx  into the muscle cell, 
leading  to phosphorylation  and activation  of calcineurin and calmodulin  dependent 
kinases.  There is numerous evidence supporting the view  that p38  MAPK (Akimoto 
et al.  2005, Knutti et  al. 2001, Puigserver  et al.  2001) and calcium  signalling 
(Handschin  et  al.  2003)  play  an  important role in  phosphorylating  and activating 
PGC-1α.  Moreover,  SIRT1  activity  provoked by  exercise appears to activate PGC-1α 
through  deacetylation  (Gurd et  al.  2009,  Rodgers et al.  2005) and finally, it has been 
suggested that reactive oxygen  species (ROS) also play  a  role in  phosphorylating 
PGC-1α  (Kang  et  al.  2009,  St-Pierre et al.  2006).  In  conclusion,  it  is obvious that  the 
exercise-induced activation of PGC-1α as a master-regulator of mitochondrial 
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biogenesis and angiogenesis in  skeletal  muscle needs a  precise coordination of all 
the aforementioned regulatory pathways. 
Fibre phenotype conversion.  A  motor  unit  is defined as the functional unit  of a 
skeletal  muscle,  consisting of one motoneuron which  innervates a  collection  of fibres 
of relatively  similar  mechanical,  biochemical, and metabolic properties (Gordon  and 
Pattullo 1993). The motor  unit  firing frequency  determines both  the amplitude and 
duration  of Ca2+ transients in  skeletal muscles. This specific  transient  change in 
cytosolic Ca2+ regulates selectively  slow- and fast-type gene programmes (Chin  et al. 
1998).  Ca2+ phosphorylates the Ca2+/calmodulin-dependent  serine/threonine 
protein  phosphatase, calcineurin  (Cn), which  in  turn  dephosphorylates the nuclear 
factor  of activated T-cells (NFAT), enabling  its nuclear  translocation  and DNA 
binding  (Fig.  1.3). Thereby, NFAT induces the activity  of slow-fibre-specific gene 
promoters (e.g. myoglobin  and troponin  I slow).  Furthermore,  chemically  inhibition 
of Cn  in rats resulted in  slow-to-fast fibre transformation (Chin  et  al.  1998),  and 
finally  mice lacking  the Cn gene showed a  decreased MYH-1  composition compared 
to wild-type mice (Parsons et  al. 2004). In  contrast, other  studies revealed that  Cn is 
not solely  responsible for  the skeletal muscle phenotype changes in  response to 
exercise (Murgia  et  al. 2000, Swoap et  al.  2000) indicating  that  the signalling 
pathways affecting the skeletal muscle phenotype is redundant.
Exercise-induced angiogenesis.  In 1977, Anderson and Henriksson  have observed 
that  endurance exercise training of 40  min cycling  on  4  days a  week  at  a  power 
corresponding  to ∼80%  peak oxygen consumption  for 8 weeks resulted in  a  20% 
increase in  capillary  density  (Anderson and Henriksson  1977). This was one of the 
first  reports to show  that capillary  density  (i.e. angiogenesis)  increases after 
endurance exercise training. Angiogenesis is defined as the  formation  of new 
capillaries from  existing  capillaries,  in  contrast to vasculogenesis, which  is defined 
as de novo  formation  of the vasculature from  precursor cells during  development 
(Prior et al.  2004). It is believed that the expansion  of the capillary  network after 
endurance exercise training  is based on  primarily  two mechanisms: 1) capillary 
intussusception and 2) sprouting angiogenesis (Fig. 1.4).
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Figure 1.3: Illustration  of the signalling  and molecular  pathways leading  to 
endurance exercise-induced adaptations in  skeletal muscle (Yan et  al.  2010).  The 
figure depicts an  adult skeletal  muscle fibre with  neuromuscular  junction, 
intracellular  metabolic  (subsarcolemmal and intermyofibrillar  mitochondria) and 
contractile (myofibrils) apparatuses,  and capillary.  Solid lines with  arrows indicate 
the findings that  have been  confirmed by  targeted gene deletion  animal studies, 
while dashed lines with  arrows indicate findings by  transgenic animal models,  but 
not yet  by  targeted gene deletion  studies.  AMPK, AMP-activated protein kinase; 
CaMK, Ca2+/calmodulin-dependent  protein  kinase; CnA,  calcineurin A; ERRα, 
nuclear  receptor  estrogen-related receptor  α; HDAC,  histone deacetylase; MEF2, 
myocyte enhancer  factor  2; NFAT,  nuclear  factor  of activated T-cells; NRF1/2, 
nuclear  respiratory  factors 1/2; PGC-1α,  peroxisome proliferator-activated receptor 
γ coactivator 1α; PKD1, protein kinase D1.
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Intussusception  is the process by  which  a  single capillary  longitudinally  splits into 
two capillaries within  the lumen  and sprouting angiogenesis refers to the branching 
out of endothelial cells from  an  existing  capillary  (Egginton  2010, Prior et al.  2004). 
The capillary  network is responsible for  the diffusive exchange of oxygen,  carbon 
dioxide,  and nutrients between  the vascular space and the intracellular  space of the 
muscle fibres.  A  functional  adaptation  to endurance exercise  training is the increase 
of oxygen  and nutrient  supply  to the working muscle  by  expanding the capillary 
network. The combination of four  stimuli is believed to mediate the endurance 
exercise-induced angiogenesis: growth  factors,  hypoxia,  shear  stress,  and 
mechanical stretch  (Prior  et  al. 2004).  VEGF has been  reported to be the most 
potent  mitogen of endothelial  cells that promotes angiogenesis in  response to 
endurance exercise training.  Mice with  a skeletal muscle-specific  Vegfa  gene 
deletion  displayed a  reduced capillary-to-fibre ratio and endurance exercise capacity 
(Olfert  et al. 2009) and an  attenuated exercise-induced angiogenesis and 
improvement  of endurance exercise capacity  (Olfert  et al.  2010). These recent 
findings indicate the pivotal role of VEGF in  the process of exercise-induced 
angiogenesis. However, an  open  question is, what the molecular  bases underlying 
the induction  of VEGF are. In  cell  culture,  it  has been  shown  that hypoxia  increases 
the VEGF mRNA  abundance through  hypoxia-inducible factor-1  (HIF-1) activated 
VEGF promoter  activity  (Forsythe et al. 1996).  HIF-1  is a  heterodimeric 
transcription  factor  composed of the HIF-1α and HIF-1β subunits and its activity  is 
post-translationally  regulated by  HIF-1α stabilisation  in  hypoxic  conditions leading 
to an increased transcriptional activation  of several HIF effector  genes (Wenger 
2000).  An  acute endurance-exercise session  has been  shown  to increase HIF-1α 
protein  and VEGF mRNA  abundances in human  skeletal muscle tissue (Ameln et al. 
2005).  However, in  a  recent  animal study  was reported that  PGC-1α regulates VEGF 
and angiogenesis in  a  HIF-independent  manner  (Arany  et  al. 2008). The notion  that 
PGC-1α  plays a  pivotal role in  the regulation  of angiogenesis was further  supported 
by  the findings that  mice with  a  muscle-specific  PGC-1α gene deletion showed a 
blunted endurance exercise-induced VEGF expression  and angiogenesis (Chinsom-
boon  et al. 2009, Geng  et  al.  2010)  and mice with  a whole-body  knockout of the 
PGC-1α gene displayed a  reduced VEGF protein  expression  and a  diminished 
response to acute and chronic endurance exercise training (Leick et al. 2009). 
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Figure 1.4: Schematic overview  of the mechanisms of exercise-induced angiogenesis 
(Egginton  2010).  Skeletal muscle activity  induces chemical and/or  mechanical 
signals which  lead to increases in the capillary  network through  vascular  endothelial 
growth  factor  (VEGF) by  two processes,  splitting angiogenesis and sprouting 
angiogenesis. 
Adaptations of skeletal muscle in response to resistance exercise
Contrary  to endurance exercise,  repeated bouts of resistance exercise increase the 
skeletal  muscle fibre cross-sectional area and/or myofibrillar length,  skeletal muscle 
mass,  and neuromuscular  strength  (Tesch  et  al.  2004).  In  parallel,  overall  capillary-
to-fibre ratio and mitochondrial volume remain  unaffected or  even  decrease in 
proportion to muscle hypertrophy  (Tesch  1988).  These structural  adaptations can 
lead to improved unspecific and/or  task-specific  strength. Basically, hypertrophy 
occurs when  the rate  of protein  synthesis is greater  than  the rate of protein 
breakdown  (Chesley  et al.  1992, Phillips et al.  1997).  The hypertrophy  response to 
overload relies on  a  complex  myriad of signalling  proteins,  in  which  the molecular 
checkpoint Akt is an important effector of anabolic signals and a dominant inhibitor
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of catabolic signals (Nader  2005). The activation of Akt  is mediated by  the insulin-
like growth  factor  1  (IGF-1)/phosphatidylinositol-3  kinase (PI3K)  pathway,  which  in 
turn  is stimulated by  IGF-1  upon  increased muscle loading (Glass 2005, Rennie et 
al.  2004, Toigo and Boutellier 2006). There are two main  pathways downstream  of 
PI3K and Akt  to mediate  hypertrophy: the Akt/mammalian  target of rapamycin 
(mTOR)  pathway, and the Akt/glycogen  synthase kinase 3β  (GSK3β) pathway  (Fig. 
1.5).  mTOR, a  Ser/Thr  protein  kinase, phosphorylates the ribosomal protein S6 
kinase (S6K1/p70S6k) and inhibits the activity  of translational repressor  eukaryotic 
initiation factor  4E-binding  protein  1  (4E-BP1/PHAS-1), which  is a  negative 
regulator  of the protein  initiation  factor  eIF4E. Inactivation  of GSK3β increases the 
rate of translation  by  increasing eIF2B activity  in  an  Akt/mTOR independent way. 
However,  recent studies with  pharmacological, genetic, and transgenic approaches 
reveal that the  mTOR signalling pathway  can  be induced in  a  PI3-kinase 
independent  way. Based on these findings, the importance of the IGF/PI-3  kinase/
Akt signalling  pathway  in  load induced muscle growth has been  questioned (Philp et 
al.  2010).  To summarise,  evidence exists that the Akt/mTOR as well  as the Akt/
GSK3β  pathways have major  effects on  skeletal  muscle  hypertrophy,  but  that  there 
are other  growth-signalling pathways in  skeletal muscle (e.g.  mitogen-activated 
protein  kinase [MAPK] and calcineurin  signalling  pathways), which  possibly  interact 
with each other leading to a significant redundancy.
Adaptations of skeletal muscle in response to concurrent training
It has been  postulated that training  to improve strength  is negatively  affected by 
concurrent  endurance exercise. Specifically,  it  has been  shown  that  simultaneous 
strength  and endurance exercise impairs strength  gains compared with  resistance 
exercise alone (Hickson  1980).  At the molecular  level, this phenomenon  has been 
explained by  a  distinct  transcriptional and (post-)  translational mechanism  of 
adaptation  induced by  resistance and endurance exercise,  with  each  mode of 
exercise activating  and/or  repressing specific subsets of genes and cellular  signalling 
pathways which can interfere with  each  other (Atherton  et  al. 2005, Baar  2006, 
Coffey  and Hawley  2007, Hawley  2009, Nader  2006).  One molecular  mechanism 
potentially  explaining the interference effect  proposes that  AMPK, activated by 
endurance exercise, phosphorylates and activates the tuberous sclerosis complex 
(TSC2, tuberin) (Atherton et al. 2005, Inoki et al. 2003). Activation of TSC2 by
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Figure 1.5:  Overview  of the signalling  mechanisms mediating  the anabolic response 
to resistance exercise (Phillips 2009).  A  multitude of kinases phosphorylates and 
thus activates or  inactivates other  kinases which  finally  lead to increased protein 
synthesis.  4E-BP1, eukaryotic  initiation  factor  4E-binding  protein  1; eIF, eukaryotic 
initiation factor; GSK3β, glycogen  synthase kinase 3β,  Int, integrin,  IGF-1, insulin-
like growth  factor  1; IR,  insulin receptor; IRS, insulin  receptor  substrate; mTOR, 
mammalian target  of rapamycin; PI3-K, phosphatidylinositol-3  kinase; TSC, 
tuberous sclerosis complex; Rheb,  rat homologue enriched in  brain; S6K1, ribosomal 
protein S6 kinase.
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AMPK is dominant  over  the resistance exercise-induced Akt-mediated inactivation, 
leading  to the inactivation  of mTOR and therefore to a  decreased rate of protein 
synthesis.  However,  although  it seems that  endurance and strength  exercise 
performed at  the same time do not  promote optimal activation  of pathways that 
simultaneously  promote both  anabolic  and endurance responses,  the underlying 
molecular mechanisms are only poorly understood.
Effects of inactivity on skeletal muscle
A  20-day  period of bed rest  by  young, healthy  male is associated with muscle 
wasting,  bone loss, insulin resistance,  reduced peak cardiac output and stroke 
volume,  orthostatic intolerance,  decreased immune function, and decreased physical 
capacity  (Saltin  et al.  1968). Moreover,  it  is not  only  extreme situations such  as bed 
rest, which  result  in  such  severe impairments in  physiological function.  A  more 
recent  study  reported that  reducing  daily  activity  level from  10’000 to 1’300 steps 
per  day  for  2  weeks, in the absence of a  structured exercise  programme,  results in 
decreases in  insulin-stimulated skeletal muscle Akt phosphorylation, peripheral 
insulin  sensitivity,  leg  lean mass, and whole-body  peak oxygen consumption  (Krogh-
Madsen  et  al.  2010). Furthermore,  inactivity  has been  associated with impaired lipid 
handling  (McGarry  2002),  skeletal  muscle capillary  regression  (Prior  et  al.  2004), 
mitochondrial dysfunction (Timmons et  al.  2006),  and a  coordinated down-
regulation of PGC-1α and genes involved with  mitochondrial metabolism  (including 
muscle substrate delivery  genes) (Timmons et  al. 2006). However,  it  is important to 
note that  molecular  changes that  initiate adaptations to detraining  are not  the 
opposite molecular  adaptations to exercise training.  For  instance, mitochondrial 
biogenesis requires about 1’500  different  nuclear-encoded proteins, whereas the loss 
of mitochondria  requires a  decline in  mitochondrial  membrane potential and 
mitochondrial autophagy  by  lysosomes,  implying different molecular  mechanisms. 
Moreover, skeletal muscle hypertrophy  reveals a  very  complex  sequence of events 
that are not the simple reverse of the muscle loss process.
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Skeletal muscle function and chronic diseases
A  multitude of molecular, structural, and functional  impairments leading  to limited 
oxidative exercise capacity  have been  attributed to several chronic diseases. Chronic 
heart  failure,  chronic obstructive pulmonary  disease, and type 2  diabetes are 
associated with  skeletal muscle dysfunction  as indicated by  reduced skeletal muscle 
fibre capillarisation,  oxidative  enzyme activity,  mitochondrial volume, and/or 
mitochondrial phosphorylation  potential  (Drexler  et  al.  1992, Duscha  et  al. 1999,  He 
et al.  2001, Jakobsson  et  al.  1995, Jobin  et  al. 1998, Kelley  et al.  2002, Larsson et al. 
1999, Sala  et  al.  1999).  Consistent with  the decreased skeletal muscle oxidative 
capacity, peak cardiac output,  whole-body  peak  oxygen consumption,  and 
endurance capacity  are impaired (Esposito et  al.  2010, Regensteiner  et  al. 2009, 
Ribisl et  al.  2007, Serres et al. 1998, Wilson  et al.  1984). Mitochondrial dysfunction 
is not only  a  common  feature of many  chronic diseases but is also associated with 
muscle atrophy  (Romanello and Sandri 2010) and ageing (Dufour  and Larsson 
2004,  Figueiredo et  al.  2008). At the molecular  level,  reports indicate that patients 
with  diabetes exhibit  coordinated reduced expression  of multiple genes involved in 
oxidative metabolism  (Mootha  et  al.  2003,  Patti et  al.  2003).  Based on  the observed 
skeletal  muscle dysfunctions in  chronic diseases,  some scientists have hypothesised 
that  these molecular, structural, and functional impairments account  for the 
aetiology  of several  chronic diseases.  For  instance,  it has been  suggested that skeletal 
muscle mitochondrial deficiency  and/or  dysfunction  causes insulin resistance, 
which  leads to diabetes (Lowell  and Shulman  2005,  Schrauwen-Hinderling  et  la. 
2007). However, the precise mechanism  behind this theory  remains unclear.  It  has 
been  hypothesised that  mitochondrial deficiency/dysfunction  impairs the ability  of 
muscle to oxidise fatty  acids,  and leads to intramuscular  lipid accumulation  and 
insulin  resistance (Kelley  et  al.  2002, Lowell  and Shulman  2005,  Morino et  al. 
2006).  In  contrast, Holloszy  (2009) recently  estimated that even  if mitochondrial 
capacity  was reduced, skeletal muscle still would contain  sufficient mitochondria  to 
allow  a  ~150-fold increase  in  oxygen  uptake per  kg of muscle under  exercise 
conditions. In  fact, Boushel et  al. (2007) reported that  although  there was a decrease 
in  mitochondrial  content,  the remaining  mitochondria  functioned normally.  Based 
on  theses findings the relationship between  mitochondrial deficiency  and insulin 
resistance has been questioned (Holloszy 2009). Thus, the important question for 
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further  studies is whether  individuals with  type 2  diabetes have a genetic 
predisposition  to low  muscle oxidative capacity, or  whether  the impaired 
mitochondrial capacity  arises from  environmental/lifestyle-related factors.  Recently, 
it  has been  suggested that  the latter  is the more likely  scenario (Hawley  and Lessard 
2007, Holloszy 2009).
Type 1 diabetes.  The American  Diabetes Association  defines type 1  diabetes as a 
metabolic  disease characterised by  hyperglycaemia  resulting from  a  cellular-
mediated autoimmune destruction  of the β-cells of the pancreas (American  Diabetes 
Association  - Position  statement  2006).  Although  type 1  diabetes commonly  occurs 
in  childhood and adolescence,  it  can  appear  at any  age, even  in  the 8th  and 9th 
decades of life. The rate of β-cell  destruction  varies during the individual  aetio-
pathology  finally  leading  to little or  no insulin  secretion.  Thus, individuals with type 
1  diabetes are dependent on  insulin  therapy  and are at  high risk  to develop keto-
acidosis,  which  is a  potentially  deadly  metabolic complication. Multiple genetic 
predispositions and poorly  defined environmental factors are believed to cause the 
autoimmune destruction  of β-cells. However, there is growing evidence that  insulin 
resistance is not  only  present in  type 2  diabetes but is also a hallmark  of type 1 
diabetes and that  also decreased β-cell function  manifests in both  forms of diabetes. 
These findings led to the assumption that  the aetiology  and conditions of type 1  and 
2  diabetes are blurring and overlapping  (Wilkin  2001,  Donath  2004). In line with 
this notion  it  has been  suggested that the gain in  visceral  fat  mass occurring  in  both 
types of diabetes might  contribute to the insulin  resistant state (Wilkin  2001).  In 
fact,  there are several reports that individuals with  type 1  diabetes display  decreased 
insulin  sensitivity  compared to healthy  controls (Nadeau  et  al.  2010, DeFronzo et al. 
1982a,b, Greenbaum  2002,  Dabelea  et  al.  2003).  Although it  is not  clear  up to now, 
if a decreased insulin  sensitivity  is associated with reduced mitochondrial capacity, 
one study  reported a  reduced mitochondrial  capacity  in  conjunction  with  increased 
glycolytic  flux  in men  with type 1  diabetes representing  a  metabolic  shift  common  to 
chronic  metabolic  diseases (Crowther  et  al.  2003).  However,  results at  the systemic 
level are contradicting  since some authors reported decreased peak oxygen  uptake 
and/or reduced submaximal cardiac output (Nadeau  et  al.  2010, Gusso et al. 2008, 
Poortmans et al.  1986), yet,  other  investigators showed that peak oxygen  uptake is 
not affected in  patients with  type 1  diabetes (Fritzsche et  al.  2008, Harmer  et  al. 
2008, Veves et  al. 1997).  Taken  together,  there  exist only  limited evidence to show 
whether aerobic function is impaired in type 1 diabetes.
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 Linking physical inactivity with chronic diseases
Although  it is challenging  to prove causality  between  physical inactivity  and chronic 
diseases,  it  is important  to note  that  in  both conditions impairments of the skeletal 
muscle are based on  the same molecular,  cellular,  structural,  and functional 
changes. In  addition,  there is not doubt that regular  exercise is a fundamental 
strategy  in  combating  many  life-style disorders. Exercise induces adaptations in 
almost  every  organ system, such  as circulatory, endocrine,  neural,  skeletal  muscle, 
connective tissue,  gastrointestinal, immune, and kidney  leading  to health 
improvements (Fig.  1.1, Booth  and Laye 2009).  Although  exercise affects all organs 
in  the body,  major  positive impacts are believed to result  directly  from  skeletal 
muscle adaptations (Kraus et  al.  2001, Yan et al.  2010). Therefore,  in  order  to gain  a 
better  understanding of the mechanisms underlying  skeletal  muscle plasticity,  it  is 
fundamental to identify  which  mechano-biological condition  leads to what 
molecular/cellular  response, and how  this molecular/cellular response relates to the 
structural,  contractile, and metabolic  adaptation  (Toigo and Boutellier  2006). An 
improved understanding of the molecular  and signalling mechanisms underlying 
exercise-induced skeletal muscle adaptation  will provide invaluable information  for 
designing therapeutic, exercise interventions for many  of the chronic diseases that 
affect people worldwide.
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Objectives
High  aerobic function  is related to physical  activity  whereas low  aerobic function  is 
related to physical  inactivity  and various metabolic diseases.  In  order  to shed light 
upon  the relationship of aerobic function  and type 1  diabetes,  we used an  integrative 
approach  to investigate factors that may  limit oxidative capacity  and aerobic exercise 
performance in  young  untrained women with  type 1  diabetes (Chapter  2). For  a 
better  understanding  of the plasticity  of the skeletal muscle aerobic function  we 
aimed at  establishing  a  cell culture model to closely  recapitulate the plastic changes 
in  gene expression  as observed in  aerobically  trained skeletal muscles of mice 
(Chapter  3). Typically, aerobic function can be improved by  repeated endurance 
exercise but not  by  resistance exercise.  To overcome the specificity  of this adaptive 
response we aimed at  designing  a  new  resistance exercise model with  superimposed 
stimuli to induce endurance type adaptations and to test its effectiveness in  humans 
(Chapter  4).  In  addition,  we aimed at analysing  the molecular bases underlying 
these adaptations (Chapter 5).
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Introduction
Oxidative capacity  depends on  the transport  of oxygen from  ambient  air  to the 
mitochondrial respiratory  chain, and relies on a  coordinated action  between  several 
processes (i.e.  ventilation, blood flow,  diffusion),  which  depends on  distinct 
structures (i.e.  lung, heart,  capillaries,  muscle fibres,  mitochondria).  Maximal 
oxygen  uptake (aerobic exercise  capacity) is determined by  convective (perfusive) 
and diffusive oxygen  transport  capacity  (Roca  et al. 1992).  Whereas convective 
oxygen  transport capacity  (i.e.  oxygen  delivery) is given  by  the product of arterial 
oxygen content  and cardiac  output, diffusive oxygen  transport  capacity  is 
determined by  arterial-mixed venous oxygen difference, which  in  turn  relies on 
capillary  supply  and mitochondrial capacity  (Saltin  et al.  1968).  Aerobic  exercise 
capacity  is reduced in  several chronic  diseases, e.g.  chronic heart  failure (Esposito et 
al.  2010),  chronic obstructive pulmonary  disease (Mador  and Bozkanat 2001),  and 
type 2 diabetes (Ribisl et al. 2007). 
While  the relationship between  reduced aerobic exercise capacity  and type 2 
diabetes is widely  accepted,  the available data  for  type 1  diabetes are  contradictory. 
Some authors report  decreased peak oxygen  uptake and/or  reduced submaximal 
cardiac output (Gusso et  al.  2008,  Nadeau  et  al.  2010, Poortmans et  al. 1986),  yet, 
other investigators showed that  peak oxygen uptake is not  affected in patients with 
type 1  diabetes (Fritzsche et al.  2008, Harmer  et  al.  2008, Veves et al. 1997). 
However,  none of these authors have concurrently  investigated both perfusive and 
diffusive components determining aerobic exercise capacity.  Using 31P-Magnetic 
Resonance Spectroscopy  (MRS), Crowther  et al.  (2003) found that mitochondrial 
capacity  (i.e. the maximal rate of oxidative ATP synthesis) is reduced in  male 
patients with  type 1  diabetes compared to healthy  controls,  and they  suggested that 
reduced muscle oxidative capacity  in conjunction with  increased glycolytic flux 
represents a  metabolic  shift common  to chronic metabolic  diseases (obesity,  type 1 
and 2  diabetes). However,  Holloszy  (2009) recently  estimated that  even if 
mitochondrial capacity was reduced, skeletal muscle still would contain sufficient 
Normal oxidative capacity in type 1 diabetes 22
mitochondria  to allow  a  ~150-fold increase in  oxygen  uptake per  kg  of muscle  under 
exercise conditions. Therefore, it  is questionable whether  and to which  extent 
reduced mitochondrial capacity  may  limit aerobic exercise capacity.  Would reduced 
mitochondrial capacity  indeed lead to reduced aerobic exercise capacity,  the 
decrease in  aerobic  exercise capacity  should manifest  itself in  a  decreased diffusive 
oxygen transport capacity. 
Taken  together, it is currently  not  well understood a) whether  oxidative capacity  is 
reduced in  patients with  type 1  diabetes at all,  b)  which  components (i.e. perfusive 
and/or diffusive)  contributing  to aerobic  exercise capacity  are reduced,  c)  whether 
the proposed reduced mitochondrial capacity  (Crowther et  al.  2003)  translates into 
reduced diffusive oxygen  transport  capacity,  and d) if glycaemic status influences 
mitochondrial capacity. In  this study  we concurrently  investigated several 
components of convective and diffusive oxygen  transport  capacity  including  muscle 
mitochondrial capacity  in  young  women  with  type 1  diabetes and healthy  women of 
similar  age and physical activity  level. To test  if aerobic  exercise capacity  and its 
determinants are reduced in patients with  type 1  diabetes, we then  compared 
maximal oxygen  uptake, maximal cardiac output,  calculated arterio-venous oxygen 
difference,  31P-MRS-derived maximal rates of calf muscle oxidative ATP synthesis, 
vastus lateralis and soleus muscle fibre metabolic  phenotype and capillarisation 
between  the two groups. In  addition,  we assessed ventilatory  threshold and 
endurance capacity  to investigate differences in  submaximal exercise capacity 
between the two groups.
Design and Methods
Participants
We recruited 29  young  sedentary  asymptomatic  women  (CON) and 9  women  of 
similar  age and activity  level  with  type 1  diabetes (DIA). Mean age was 24.1  (SD 4.2) 
years for  CON and 26.9  (5.2) years for  DIA  without significant  difference.  The 
participants' anthropometric data are presented in Table 2.1. Women with type 1 
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diabetes had no diabetic  complications or  coexisting  cardiovascular  diseases,  and 
were classified as C-peptide negative (< 0.5  µU⋅ml−1). The duration  of diabetes was 
13.1  (6.6) years. Relative (per  kg  body  mass) mean total  daily  insulin  dose was 0.6 
(0.3) units⋅kg−1. Glycosylated haemoglobin  A1c  (HbA1c) was 5.3  (0.2)  (range 
5.0-5.7%) and 7.6  (0.4) % (range 6.9-8.2%) for  CON and DIA, respectively, and 
different between  groups (P < 0.001).  Participants in the CON group showed no sign 
of either  impaired glucose tolerance [fasting  glucose concentration: 4.49  {0.26} 
mmol⋅l−1,  blood glucose concentration  2  h  post glucose load:4.92  {1.19} mmol⋅l−1 
(Unwin et  al.  2002)] or calculated insulin resistance [homeostasis model assessment 
{HOMA-IR (Matthews et al.  1985)}: 1.4  {0.4}]. All participants were untrained (less 
than  1  h  of physical  activity  per  week).  After  completing  a  routine health 
questionnaire the participants were informed about the applied procedures and the 
associated risks. Informed written  consent was obtained from  all participants. The 
experimental protocol  was approved by  the ethics committee of the  canton  of 
Zurich, and the study  was performed in  accordance with  the ethical  standards laid 
down in the Declaration of Helsinki for human experimentation.
Magnetic resonance spectroscopy and imaging measurements
31P-MRS scans were acquired at  rest  and during isometric  muscle contraction  using 
a  3  T whole body  Philips Achieva Scanner  (Philips Healthcare, Best, The Nether-
lands) with  a  transmit/receive  surface coil (diameter: 0.14  m) tuned to 51.8  MHz. 
The MR-compatible ergometer  setup was compound of a  dynamometer  with  an 
integrated strain  gauge (Sensory-Motor  Lab, ETH  Zurich,  Switzerland)  for  force 
measurements and a  real-time visual  feedback system  for  providing  the participants 
with  information on  the level of exerted force relative to maximal  voluntary  force. 
31P-MRS spectra  of the triceps surae muscles were acquired using  a  pulse-acquire 
technique and an adiabatic hyperbolic secant excitation  pulse. The test protocol 
consisted of isometric plantarflexion at 85% of the maximal force acting on the pedal 
(MVFP)  for  30 s. Sequence parameters included: repetition  time = 1.5  s,  3  signal 
averages per  time point,  2048 sample points, 5  dummy  scans; 20  spectra  were 
recorded before the exercise for  saturation correction; total number of spectra: 84. 
Recovery  spectra were measured after  cessation of the isometric contraction  for  324 
s.  The reasons for  this test  protocol  were that  1) pH remains close to 7.0, which  is 
mandatory to derive valid phosphocreatine (PCr) recovery rates (Arnold et al. 1984),  
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2) at  85%  MVFP motor  unit  recruitment of large muscles is complete  (DeLuca  et  al. 
1996),  and 3) the obtained mean  decrease in  PCr  concentration  is sufficiently  high  to 
calculate PCr recovery rate (kPCr) (Meyer 1988). 
Processing: Free-induction  decays were zero-filled,  line-broadened, Fourier-
transformed into spectra,  and fitted using  tdfdfit (Slotboom  et  al. 1998).  Inorganic 
phosphate (Pi) and PCr  concentrations were calculated using  ATP as internal 
reference standard,  assuming a  concentration  of 8.2  mM (Arnold et al.  1984). The 
saturation factor  in the dynamic spectra  was determined by  the ratio of the relaxed 
spectra  to the partially  saturated spectra  acquired prior  to the plantarflexion 
exercise.  We calculated kPCr,  which  is an  indirect marker  for  the maximal rate of 
oxidative ATP synthesis (Sahlin 1978),  using  a  mono-exponential fitting  procedure. 
Oxidative capacity  was calculated as the product between  kPCr and resting  PCr 
concentration  (Conley  et al.  2000).  Intracellular  pH-values were calculated from  the 
chemical shift of Pi according  to the modified Henderson-Hasselbach  equation 
(Petroff et al. 1988). 
Skeletal muscle biopsy analyses
Sample preparation. We obtained percutaneous biopsies from  the middle region of 
the nondominant  soleus  and vastus  lateralis  muscles,  using  a  ProMag  Ultra  device 
and 14  gauge needles (Angiotech Pharmaceuticals, Gainesville, FL, USA). Muscle 
tissue was mounted in  an embedding medium  (Tissue-Tek®, Sakura,  Zoeterwoude, 
The Netherlands),  snap frozen  in  isopentane cooled to −160 °C with  liquid nitrogen. 
We stained the serial cryocut  cross-sections using  the myofibrillar  adenosine-
triphosphatase (mATPase) method according  to Guth  and Samaha  (1970) with 
minor modifications (Muentener  1979). Muscle fibres were classified according  to 
their  myosin  heavy  chain  (MYH) isoform  into MYH-1  and MYH-2.  For  the analysis 
of oxidative enzyme activity, we incubated consecutive sections in  media  containing 
cytochrome c  oxidase.  The monoclonal  mouse anti-human  CD31  endothelial cell 
antibody  (DAKO, Carpinteria,  Canada, 1:600 dilution) was used as a  marker  for 
muscle, and capillary-to-fibre ratio was calculated by  dividing  the number  of CD31-
positive cells by  the number  of muscle fibres.  For  all  histochemical  and 
immunohistochemical  analyses, we used the NIH Image J software (1.41o, National 
Institutes of Health, Bethesda, MD, USA). Cytochrome c activity was determined 
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from  the measured mean  optical  density  pixel values of the muscle  fibres normalised 
to the background pixel  values on  the same section, and reported in  arbitrary 
numbers. For  all fibre analyses,  only  fibres fully  encircled by  adjacent  fibres were 
evaluated,  and measurements were made for  at  least  50  of each  of the main fibre 
types (i.e.  MYH-1  and MYH-2). Previous studies investigating  the skeletal muscle 
fibre sample size required for  a reliable,  valid representation  of an  individual's 
average fibre area and capillary-to-fibre ratio,  showed that 50  fibre measurements 
per  individual  for  type 1  and 2  fibres and capillary  contacts are sufficient  to 
characterise type 1  and 2  fibre areas and capillary-to-fibre ratio of an  individual 
(McCall et al. 1998, Porter et al. 2002).
Cardiac output and oxygen consumption measurements
We used Innocor™ (Innovision, Odense, Denmark) to estimate cardiac output  by 
inert  gas rebreathing  and oxygen  consumption  by  breath-by-breath  ergospirometry 
during  a  graded cycling exercise test  (GXT),  as previously  described (Fontana et  al. 
2009).  Participants started cycling  at  50  W  and power  was increased by  25  W  every 
2  min  until volitional exhaustion. Arterio-venous oxygen  difference was calculated 
by  dividing oxygen consumption  by  cardiac output. Ventilatory  threshold was 
determined as the power  corresponding  with  a  disproportionate increase in  minute 
ventilation during the GXT.
Endurance capacity
On a  separate day, we used a  constant-load cycling  exercise test (CLT) to assess time 
to exhaustion  at  submaximal  power  as an indicator  of endurance capacity. Power  of 
the initial warm-up stage was 40% maximal power  of the first  GXT.  After  1  min, we 
increased power  to 60% peak power (for 2  min) and then  to 85% maximal  power. 
Power  at 85%  maximal power  was sustained until  volitional exhaustion,  i.e.  the 
point  in  time at  which  the participants stopped pedalling  or  were no longer  able to 
maintain pedal rate within the required limits.
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Dual-energy X-ray absorptiometry 
We performed dual-energy  X-ray  absorptiometry  (DXA) measurements using  Lunar 
iDXA™ (GE Healthcare, Madison, WI, USA).
Blood analyses
Plasma  glucose concentrations were determined by  an automated hexokinase 
method (HK Unit-Kit  III,  Roche, Basel,  Switzerland), and serum  insulin 
concentrations were determined by  radioimmunoassay  (Insulin  ct-kit, Cisbio 
Bioassays, Bagnols-sur-Cèze, France). HbA1c was immunochemically  determined 
with  a  DCA  2000®  device (Bayer, Leverkusen, Germany).  Furthermore,  CON 
participants performed a  standard 75  g-oral glucose tolerance test  (OGTT) in  the 
morning after an overnight (12 h) fast.
Statistical analyses
Data  are presented as mean  and standard deviation  (SD).  Group differences between 
CON and DIA  were tested for  statistical significance by  t-tests for  independent 
samples, and equality  of variances was checked using  Levene’s test.  The level of 
significance was set to P < 0.05. For  all statistical  analyses, SPSS 16.0  statistical 
software (SPSS, Chicago, IL, USA) was used.
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Results
Calf muscle mitochondrial capacity
As indicated by  the identical post-exercise kPCr for  CON and DIA [0.0307  (0.0070) 
and 0.0309 (0.0058) s−1, respectively],  calculated from  the PCr  recovery  over time 
(Fig.  2.1A), calf muscle mitochondrial capacity  was not  different  (P = 0.930) 
between  the two groups. pH  did not affect  PCr recovery,  as shown  by  the 
independency  of kPCr from  pH (Fig. 2.1B). For  both, CON and DIA,  the end-exercise 
pH values were  close to 7.0 and not  different from  the values at  rest  [CON: 7.03 
(0.06) vs. 7.03  (0.02),  P = 0.846; DIA: 7.02  (0.10) vs. 7.03  (0.01), P = 0.707]. 
Between  groups,  there were no differences in  either  resting  (P = 0.262) or  end-
exercise pH (P = 0.845, Fig. 2.1C). The calculated calf muscle oxidative capacity  [1.15 
(0.28)  vs.  1.19  (0.30) mM⋅s−1, P = 0.702], resting  Pi concentrations [4.87  (0.75) vs. 
4.67  (0.57) mM,  P = 0.467]  and resting PCr  concentrations (P = 0.669, Fig. 2.1A) 
were similar between CON and DIA.
Skeletal muscle fibre properties
For  both,  vastus  lateralis  and soleus  muscles,  no differences in  capillary-to-fibre 
ratio and MYH-1  fibre percentage were found between  CON and DIA (Fig. 2.2A, B). 
The oxidative fibre phenotype was not  different  between  CON and DIA, as indicated 
by  the similar  cytochrome c oxidase  activity  in  MYH-1  and MYH-2  fibres (Fig.  2.2C). 
In  general, muscle fibre diameters tended to be smaller  for  CON relative to DIA  (Fig. 
2.2D).  However,  only  the vastus  lateralis  muscle MYH-2  mean  fibre diameter  was 
significantly (P = 0.006) smaller in CON than in DIA (Fig. 2.2D).
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Figure 2.1: Phosphocreatine concentration  (cPCr)  during isometric plantarflexion 
exercise (A), relationship between  PCr  recovery  rate constant  (kPCr) and end-exercise 
pH (B),  and time course of pH during isometric  plantarflexion  exercise (C).  Squares 
and dashes represent  means and SD,  respectively,  for 28 and 9  women  in  CON and 
DIA,  respectively.  One individual in  the CON group was excluded from  the kPCr data 
set  because of a kPCr value more than  4  SD from  the mean. Dashed vertical  lines in 
(A)  and (C) indicate  the start  and end of exercise. CON, healthy  women; DIA, 
women with type 1 diabetes. No significant differences were found.
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Figure 2.2: Capillary-to-fibre ratio (A), MYH-1  fibre percentage (B), cytochrome c 
(cyt  c) oxidase  activity  (C),  and fibre diameter  (D) of soleus  (SOL) and vastus 
lateralis  (VL) muscle fibres. Bars and error  bars represent  mean  values and 
standard deviations, respectively.  Only  datasets meeting the described quality 
criteria  were included (soleus muscle MYH-1  fibre percentage: 9  CON and 5  DIA; 
vastus lateralis  muscle MYH-1  fibre percentage: 13  CON and 6  DIA; cyt c  oxidase 
activity  and fibre diameter: 14  CON and 6  DIA; soleus  muscle capillary-to-fibre 
ratio: 15  CON and 5  DIA; vastus  lateralis capillary-to-fibre ratio: 14  CON and 6 
DIA). AU, arbitrary  units; MYH-1,  myosin  heavy  chain  isoform  type 1; MYH-2, 
myosin  heavy  chain  isoform  type 2; CON, healthy  women; DIA, women  with  type 1 
diabetes. *P < 0.05.
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Oxygen consumption, cardiac output, and arterio-venous oxygen 
difference
Oxygen  consumption, cardiac output,  and calculated arterio-venous oxygen 
difference were not different  between  CON and DIA  at maximal and submaximal 
power during a GXT (Fig. 2.3). 
Figure 2.3: Oxygen consumption (A),  cardiac output  (B),  and calculated arterio-
venous oxygen  difference (C) at  submaximal and maximal power  during a  GXT to 
exhaustion. Bars and error bars represent mean  values and SD, respectively, for  29 
healthy  women  (CON) and seven  women  with  type 1  diabetes (DIA). Two individuals 
in  the DIA  group did not agreed to participate in  a  GXT. GXT, graded cycling 
exercise test. No significant differences were found.
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Exercise performance, ventilatory threshold and endurance 
capacity
We found no difference in maximal power  output  [163  (26)  vs.  171  (25)  W, P = 
0.486]  and ventilatory  threshold [124  (18) vs.  125  (17) W,  P = 0.942]  between CON 
and DIA  during  a  GXT.  Furthermore,  cycling endurance capacity  was not  different 
between  the two groups, as indicated by  the similar  cycling  time to exhaustion 
[CON: 532 (212) s, DIA: 471 (119) s, P = 0.475] during a CLT at submaximal power.
Effect of glycaemic control on mitochondrial capacity and cardiac 
output
HbA1c was negatively  correlated with  kPCr (R2 = 0.475,  P = 0.040,  Fig. 2.4A) and 
peak cardiac  output (R2 = 0.742, P = 0.013; Fig.  2.4B) in  women with  type 1 
diabetes.
Figure 2.4: PCr  recovery  rate constant (kPCr) (A) and peak cardiac  output (B) as a 
function of glycosylated haemoglobin  A1c (HbA1c) in  nine (A)  and seven  (B) young 
untrained women with type 1 diabetes.
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Body composition
Both, total and segmental  lean and fat  masses, were lower in  CON relative to DIA, 
while % body fat was the same in both groups (Tab. 2.1).
Table 2.1: Body composition of study participants
Data  are expressed as means (SD) for  29  healthy  women  (CON) and 9  women with 
type 1 diabetes (DIA). *P < 0.05, **P < 0.01.
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Discussion
The aim  of the present  study  was to determine whether  oxidative capacity  is reduced 
in  women  with  type 1  diabetes and whether  their  glycaemic status influences 
mitochondrial capacity.  We found that  in  women  with  type 1  diabetes, glycaemic 
status affected mitochondrial capacity  and cardiac output, but  that  maximal oxygen 
uptake, maximal cardiac output, calculated arterio-venous oxygen  difference,  in vivo 
skeletal  muscle mitochondrial  capacity,  muscle fibre metabolic  phenotype, and 
capillarisation  were not  different  between women  with  type 1  diabetes and healthy 
women  of similar  age and physical  activity  level.  Analogous to maximal  aerobic 
capacity,  we found that  ventilatory  threshold and endurance capacity  were similar 
between  the two groups.  Our  results indicate that  glycaemic  status affects 
mitochondrial capacity  in  women  with  type 1  diabetes,  but  that  neither  maximal  nor 
submaximal aerobic capacity  is reduced in young  women  with  type 1  diabetes 
relative to healthy controls.
To obtain  maximal  rates of oxidative ATP synthesis we applied a test protocol that 
decreased skeletal  muscle PCr  concentration  but left  intracellular  pH close  to 7.0 
(Fig.  1), the latter  being  crucial to derive valid PCr recovery  rates (Arnold et al. 
1984).  Our  finding  that the maximal  rate of oxidative ATP synthesis (mitochondrial 
capacity)  was similar  between  women  with  type 1  diabetes compared to healthy 
controls (Fig. 2.1) conflicts with  that of Crowther  et  al.  (2003),  who reported slower 
PCr  recovery  rates in  men with  type 1  diabetes relative to age-matched controls. 
Three reasons could possibly  help to explain  the divergent findings.  A  first reason 
might  be that Crowther  et  al.  (2003) determined oxidative capacity  from  isometric 
dorsiflexions while we used isometric plantarflexions. Thus,  differences in  oxidative 
metabolism  between  dorsiflexion  and plantarflexion  muscles might  lead to divergent 
findings.  But  given the fact that  MYH-1  fibre type proportion  of tibialis anterior 
muscle lies between  that of soleus  and gastrocnemius  muscles (Saltin  et  al. 1977),  it 
seems unlikely  that differences in  fibre type distribution  represent  a  reason  for 
discrepancy. A second possible reason might be that in the study by Crowther et al.
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(2003) the participants were not  able to sustain  the target  force  of 70-75% MVFP for 
30 s [Figure 2A  in  (Crowther  et  al.  2003)].  Therefore, the drop in  pH might have 
varied between  participants, affecting the calculation of PCr  recovery  rates. We 
avoided this possible drawback  by  providing  the participants with  a  real-time visual 
feedback on  FP relative to MVFP.  This way  all our  study  participants sustained the 
target  force of 85%  MVFP for  30 s.  Finally,  the discrepancy  between  our  results and 
those of Crowther  et  al.  (2003) might  originate from  sex-specific differences in  the 
maximal rate of oxidative ATP synthesis.
Our  findings that  cytochrome c oxidase activity, capillary-to-fibre ratio, and MYH-1 
fibre proportion  of vastus  lateralis  and soleus  muscles were not different  between 
the two groups support our  result  that in vivo  mitochondrial function  was not 
impaired in  women  with  type 1  diabetes,  and lend further credence to the notion 
that  oxidative capacity  is not  reduced in  type 1  diabetes.  In line with  our  results, 
other authors found no difference in  vastus  lateralis muscle succinate dehydro-
genase activity  (Fritzsche et  al. 2008), skeletal muscle  capillary-to-fibre ratio and 
fibre type distribution  in  vastus lateralis  muscle (Wallberg-Henriksson  et al. 1984) 
between  patients with  type 1  diabetes and healthy  controls.  However,  there are also 
reports showing  that  MYH-1  fibre proportion in  women  and men  with  type 1 
diabetes (Fritzsche et  al.  2008)  is reduced. Besides muscle fibre metabolism, 
oxidative capacity  also depends on muscle capillarisation.  In  fact,  the size of the 
capillary  network  determines mean red blood cell transit  time and surface area for 
gas exchange and may  also influence the exchange of substrates and metabolites and 
removal of heat (Saltin et  al.  1986).  However,  capillary  density  relates more to 
submaximal (e.g.  endurance capacity  and ventilatory  threshold) than  to maximal 
measures (Saltin  et  al.  1968). In  this study, neither  capillarisation  nor endurance 
capacity  or  ventilatory  threshold were reduced in  women  with  type 1  diabetes 
relative to healthy  controls, indicating that submaximal  aerobic exercise capacity 
was not impaired in women with type 1 diabetes. 
It has been  unclear  up to now, whether maximal oxygen uptake and exercise 
performance (i.e.  maximal  power output during  a GXT) are  reduced in  type 1 
diabetes. While some authors reported that  adolescents with  type 1  diabetes display 
both  reduced oxygen  uptake (Gusso et al.  2008,  Nadeau  et  al. 2010)  and peak power 
(Nadeau  et  al.  2010) other  investigators showed that  these measures are unchanged 
in adults with type 1 diabetes (Fritzsche et al. 2008, Harmer et al. 2008, Veves et al. 
Normal oxidative capacity in type 1 diabetes 35
1997).  Here,  we showed that neither maximal oxygen uptake (Fig.  2.3A) nor 
maximal power  during  a GXT was different  between  patients with  type 1  diabetes 
and healthy  controls. Furthermore,  the similar  maximal oxygen uptake between the 
two groups relied on  similar  perfusive (cardiac  output,  Fig.  2.3B) and diffusive 
(calculated arterio-venous oxygen  difference,  Fig. 2.3C)  oxygen  transport capacities, 
indicating that  submaximal and maximal  oxygen  uptake, delivery  and extraction  are 
not reduced in women with type 1 diabetes.
It is well  established that reduced insulin sensitivity  is a prominent  feature of type 2 
diabetes. However, reduced insulin  sensitivity  can also be found in  individuals with 
type 1  diabetes (DeFronzo et al. 1982,  Harmer  et  al. 2008). We did not  assess insulin 
sensitivity  in  this study  and thus cannot quantify  to which  degree the type 1  diabetes 
participants were insulin  resistant. Nevertheless, according  to evidence indicating 
that  type 1  diabetes patients are insulin  resistant  to some degree, and assuming  that 
the type 1  individuals who participated in  this study  were not different in  this regard, 
our  data might  be interpreted to support  the suggestion of other  scientists (Holloszy 
2009) that insulin  resistance is not  the consequence of reduced oxidative capacity. 
Our  finding that  skeletal muscle mitochondrial  capacity  was not  impaired in  women 
with  type 1  diabetes despite higher  total  and segmental fat  masses (Tab.  2.1) 
supports this speculation, i.e.  that reduced oxidative capacity  is not instrumental  to 
insulin  resistance,  especially  in  light of the negative correlation  between  both 
abdominal (Carey  et  al.  1996) and thigh  fat (Goodpaster  et al.  1997) and insulin 
sensitivity. 
HbA1c levels above 7% are indicative of poor glycaemic control in  type 1  diabetes 
(American  Diabetes Association  2008).  In  this regard, it has recently  been shown 
that  endurance athletes with  type 1  diabetes and high  (> 7%) HbA1c  have lower peak 
oxygen  consumption, peak  stroke volume, and peak cardiac  output relative to 
athletes with  low  (< 7%) HbA1c (Baldi et  al.  2010),  and that  HbA1c negatively 
correlates with  peak stroke volume.  Although  we did not find a reduced 
mitochondrial capacity  and aerobic  exercise capacity  in  women  with  type 1  diabetes 
with  a mean HbA1c of 7.6% (range 6.9-8.2%) relative to healthy  female participants, 
linear  regression revealed that  women with  type 1  diabetes exhibiting  higher  HbA1c 
have a  lower kPCr and peak cardiac output (Fig.  2.4).  Taken together, these data 
might  be interpreted to support  the notion that in type 1  diabetes,  oxidative capacity 
is correlated with glycaemic control, but that only at higher HbA1c levels (> 7.6%)
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the impairment becomes significant relative to untrained healthy women. 
We do acknowledge some limitations with the current  investigation.  For  example, 
we calculated arterio-venous oxygen  difference from  the estimated oxygen  uptake 
and cardiac output according  to the Fick principle,  instead of calculating  arterio-
venous oxygen difference and oxygen extraction  from  measured arterial  and venous 
oxygen  content and arterial oxygen concentration. A  further  limitation  is that  we did 
not directly  estimate insulin  sensitivity  from  euglycaemic  hyperinsulinaemic clamps 
nor hepatic  glucose production. However, the primary  aim  of this study  was to 
determine the relationship between type 1  diabetes and oxidative capacity, 
irrespective of the degree of insulin  resistance.  We thus feel like our approach of 
combining non-invasive inert  gas rebreathing with  gas exchange measurements (to 
assess maximal oxygen uptake and cardiac output),  to subsequently  calculate stroke 
volume and arterio-venous oxygen  difference according  to the Fick principle, and to 
relate these systemic measures with  in vivo  maximal  mitochondrial ATP synthesis 
rate and oxidative markers from  muscle biopsies,  provides novel  information  about 
the relationship between oxidative capacity  and its underlying  components in  type 1 
diabetes.
In  summary, maximal oxygen  uptake,  maximal  cardiac  output  and calculated 
arterio-venous oxygen  difference,  as well  as 31P-MRS-derived maximal rates of calf 
muscle oxidative ATP synthesis,  vastus lateralis  and soleus  muscle fibre metabolic 
phenotype and capillarisation  were not different  between  young  women  with  type 1 
diabetes and healthy  women of similar age and activity  level.  Also,  we found no 
difference in  ventilatory  threshold and endurance capacity  between the two groups. 
However,  in  women  with  type 1  diabetes,  glycaemic status affected oxidative 
capacity.  We conclude that  in  young  untrained women  with  type 1  diabetes and a 
mean  HbA1c  of 7.6% (range 6.9-8.2%), glycaemic  status affects mitochondrial 
capacity  and peak cardiac output,  but that  neither maximal nor  submaximal aerobic 
capacity is reduced relative to healthy women of similar age and activity level.
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Introduction
Physical activity  results in  a  number  of phenotypic  adaptations of skeletal muscle 
(Booth  and Thomason 1991,  Flueck  2006).  If performed repeatedly, exercise thereby 
confers health  benefits by  preventing  and ameliorating  a  number  of chronic 
diseases,  improving  the quality  of life and increasing life expectancy  (Handschin  and 
Spiegelman 2008).  Intriguingly  though,  the molecular  mechanisms that underlie the 
corresponding  plastic changes of muscle fibres are poorly  defined.  Progress in 
understanding  these mechanisms would be facilitated by  an  experimentally 
amenable cell  culture model.  Electrical  and mechanical signals, e.g.  motor  neuron 
activity  and muscle fibre stretch, are two of the major  exercise-associated stimuli 
that  result in  a  remodelling  of muscle fibres. Motor  neuron  activation  of muscle 
fibres can  be replicated by  electric  pulse stimulation  (EPS)  of muscle myotubes in 
culture. For  example,  electrical  stimulation  of muscle cells in  culture increases 
contractile properties (Thelen et  al. 1997) and accelerates sarcomere assembly 
(Fujita  et al.  2007). Furthermore, EPS-induced changes in gene expression  patterns 
and metabolic properties have been  reported (Nedachi  et  al.  2008, Park  et  al.  2008, 
Silveira  et  al.  2006). Unfortunately,  the effects of electric  stimulation  on  the 
development and function  of cultured muscle cells remain  controversial and vary 
between  different  muscle cell types and stimulation  conditions (Naumann  and Pette 
1994, Pedrotty et al. 2005, Putman et al. 2000, Stern-Straeter et al. 2005).
To study  exercise effects in  an  experimental cultured muscle fibre model,  the gene 
expression  changes triggered by  exercise in vivo  and the modulation  of 
transcriptional activity  of cultured,  EPS-stimulated muscle cells have to be 
compared.  Obviously  though,  in vivo,  these changes differ  dramatically  between  the 
acute response to a  single bout  of exercise and the chronic effects of training  on 
muscle, with  the latter  conferring most  of the health  benefits (Booth  et  al.  2002, 
Booth  and Lees 2007, Coffey  and Hawley  2006).  Despite the distinct  outcome, some 
of the signalling pathways are conserved in both  cases. For  example,  the expression 
of the peroxisome proliferator-activated receptor γ 
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coactivator  1α  (PGC-1α)  in  humans and rodents is temporarily  elevated after  each 
exercise bout  (Norrbom  et al. 2004,  Pilegaard et  al.  2005, Terada  et al. 2002),  and 
exhibits a  persistent  basal elevation  after  chronic  endurance training  (Goto et  al. 
2000, Russell  et al. 2003, Taylor  et al.  2005) while maintaining additional 
inducibility  with  physical activity  (Pilegaard et  al.  2003, Coffey  et  al.  2006).  The 
acute increase of PGC-1α levels and activity  might  primarily  be responsible for 
increased oxidative metabolism  and hence an  elevated ATP synthesis (St-Pierre et 
al.  2003, Wright et al.  2007,  Wu  et  al.  1999). Chronic  elevation  of PGC-1α is 
associated with  a  fibre-type switch  from  the glycolytic, fast-twitch  type IIB and IIX 
fibres towards the oxidative,  high-endurance type IIA  and I muscle fibres 
(Handschin  et  al.  2007,  Lin  et  al.  2002) as well as an  increase in  vascularisation 
(Arany  et al.  2008).  In  fact,  PGC-1α seems to regulate many, if not  all of the 
adaptations of muscle fibres to chronic endurance training (Finck and Kelly  2006, 
Handschin  and Spiegelman 2008, Handschin  et  al.  2007a,  b, c, Handschin  2009, 
Lin  et  al.  2005)  and leads to improved exercise performance as well as increased 
peak oxygen uptake (Calvo et al. 2008).
We aimed at  establishing  and validating  an EPS condition  that  induces a  gene 
expression  pattern  resembling  that  of a  trained muscle. For  that  purpose, we tested 
EPS protocols in  different  muscle cell types,  and because of the versatility  and 
robustness of PGC-1α induction  in  the trained muscle (Vissing et al. 2005), we 
measured the expression  of this gene as a  prototypical exercise gene. Subsequently, 
the level  of key  genes in  mitochondrial  function,  substrate uptake and oxidation 
were determined.  The EPS-triggered changes of these genes in  muscle  fibres in 
culture were then compared to those in  acutely  exercised and trained mice, 
respectively.  Our  data  suggest  that  the proper  EPS conditions in  muscle cells in 
culture qualitatively  recapitulate some of the gene expression  patterns observed in 
trained muscle.
In vitro exercise system  41
Design and methods
Chemicals and cell culture reagents
Dulbecco’s modified Eagle’s medium  (DMEM), fetal bovine serum  (FBS), 
phosphate-buffered saline (PBS, calcium- and magnesium-free),  1x  trypsin-EDTA, 
penicillin-streptomycin  (P/S),  and horse serum  (HS) were purchased from 
Invitrogen  (Basel,  Switzerland). Bovine serum  albumin  (BSA) was obtained from 
Sigma  (Buchs,  Switzerland).  SYBR-green  was purchased from  Sigma  (Buchs, 
Switzerland).  Trizol,  reagents for  DNase digestion  and reverse transcription were 
obtained from  Invitrogen (Basel,  Switzerland).  Real-time PCR primers were 
synthesised by Microsynth (Balgach, Switzerland).
Cell culture conditions
C2C12  (CRL-1772)  and SOL8  (CRL-2174) cells were obtained from  the American 
Type Culture Collection  (ATCC) and cultured at  37°C  in  5% CO2 on  100-mm  plastic 
dishes containing culture medium. These cell  lines are  standard mouse muscle cells 
that  were obtained from  glycolytic  and oxidative muscles, respectively, and that are 
widely  used as a  cell culture model for  muscle in  culture.  Culture medium  consisted 
of DMEM supplemented with  1% P/S and 10% FBS for  C2C12  and 20% for  SOL8, 
respectively.  For  the experiments,  the cells were distributed onto 6  well plates 
(Corning, New  York,  USA).  Upon  reaching about  90% of cell  confluence,  the culture 
medium  was switched to differentiation medium  consisting  of DMEM supplemented 
with  1% penicillin/streptomycin and 2% horse serum. This differentiation  medium 
was changed every  24  h.  After  4-6  days, differentiation  into myotubes was 
completed and the cells used for EPS.
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Electric pulse stimulation (EPS)
EPS was applied to myotubes with  a  C-Pace EP culture pacer  (IonOptix,  Dublin, 
Ireland).  This instrument emits bipolar  pulses to the carbon electrodes of the C-dish 
with  the electrodes hanging  in  the cell culture media.  The contraction  paradigm 
consisted of 1-s trains with  1-s pauses between  the trains.  During  the 1-s trains,  a  1-
ms pulse stimulus with  14  V  and a  frequency  of 50  Hz was applied. These 1-ms 
pulses most  likely  result  in  a  combined activation  of action  potentials and the 
dihydropyridine receptor  system  (Cairns et al. 2007).  The contractions of the 
myotubes were verified by  examination under  microscope. C2C12  and SOL8 cells 
were EPS treated either  for  90  min (“acute” protocol),  for  90  min each  on  4 
consecutive days at  regular  time intervals (“intermittent”  protocol) or  for  24 
consecutive h  (“continuous”  protocol).  Differentiation  medium  was exchanged 1  h 
before the stimulation  was started.  In  order  to test serum-free conditions,  BSA 
medium  (DMEM supplemented with  1% P/S and 0.1% BSA) was added to three 
wells of C2C12  cells instead of differentiation  medium  on the third and fourth  day  of 
stimulation or  for  the 24  h  of stimulation.  Cells were harvested in  1  ml Trizol 3  h 
after EPS similar to previous studies (Silveira et al. 2006).
Animal experiments
All  procedures were approved by  the Veterinary  office of the canton  of Zurich  and 
performed following  institutional guidelines.  Male wild-type C57Bl/6J mice (age: 6 
weeks, body  weight: between  20 and 25  g) were maintained in  cages with a  12  h:12  h 
light-dark  cycle starting  at 6:00 in  a  room  at 22° C. Food and water  were available 
ad libitum. The mice were randomly  divided into experimental groups with  seven 
(chronic)  or  eight (acute)  mice per  group.  Exercise training was performed at  the 
same time each  day  during  the light  cycle. At  the end of the experiment, mice were 
sacrificed by  CO2 inhalation, blood was collected by  cardiac puncture and death 
ensured by cervical dislocation.
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Treadmill exercise
Mice were first  familiarised with  treadmill  running  for  3  days. The treadmill 
(Columbus Instruments, Ohio, USA) was equipped with  an electric  stimulation grid 
at  the rear. The duration  of these familiarisation runs was 5  min  with  a speed of 6 
m⋅min−1 and an  incline of +5°.  On  the day  after familiarisation, body  weights were 
measured and a  forced incremental exercise test to exhaustion was performed. This 
test  was started with  an  incline (α)  of +5° and a speed of 6  m⋅min−1 for  5  min.  After 
this initial phase,  the  speed was progressively  increased by  2  m⋅min−1 every  3  min. 
Animals ran until  exhaustion, which  was defined as the inability  to remain on  the 
treadmill  despite  repeated contact with  the electric grid (0.4  mA)  and mechanical 
prodding  for  more than 10  s.  Once exhaustion  was reached,  the power  of the shock 
grid was turned off. Running  time was measured and running  distance,  work and 
power  were calculated. Distance is a  function of time and speed (Distance = 
vtreadmill⋅t).  Work is the product  of body  mass, gravity,  vertical  speed and time (Work 
= mmouse⋅g⋅vtreadmill⋅tan[α]⋅t).  Power  is calculated as the product  of body  mass, gravity 
and vertical  speed (Power  = mmouse⋅g⋅vtreadmill⋅tan[α]). The group that  underwent 
training recovered for  2  days. Subsequently, these mice trained using  the same 
treadmill  protocol  until 75% of the average distance of all  the mice from  the last 
exhaustion  trial  was reached.  This training  was performed on  4  days of the week, 
while the 5th day  was used for  a new  exhaustion test. This procedure (4  days 
training,  1  day  exhaustion  trial and 2  days of rest)  was repeated for  a  total of 6  weeks 
when  the gains in  endurance parameters were significantly  increased over  those of 
control  mice for  two weeks in  a  row.  The control group was kept at standard, 
sedentary  conditions. All  the mice were anesthetised with isofluran  (Provet,  Lyssach, 
Switzerland)  either 4  h  after  the single performance trial  for  the acute exercise group 
or  3  days after  their  last endurance trial  for  the chronic exercise group. Animals were 
sacrificed by  CO2 inhalation,  blood was collected by  cardiac  puncture before death 
was ensured by cervical dislocation.
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Gene expression analysis and Western blots
Mice were dissected and muscle gastrocnemius  was prepared. The frozen 
gastrocnemius  was pulverised and RNA  prepared using  Trizol reagent  according  to 
the manufacturer’s instructions (Invitrogen). C2C12  and SOL8  cells were directly 
lysed in  Trizol reagent and subsequently  processed. The purity  of the resulting RNA 
was assessed by  the 260 nm/280  nm  ratio. Subsequently, DNase I digestion was 
performed and 1  µg of total  RNA  was reverse transcribed.  Relative gene expression 
levels were determined by  real time polymerase chain  reaction  using  SYBR-green  on 
an  Mx3000P QPCR System  (Stratagene,  La  Jolla,  USA) according to the ΔΔCt 
method. Relative gene expression was normalised to 18S rRNA  and TATA  box 
binding  protein (TBP) levels. The following  primers were used: PGC-1α (forward 
TGA  TGT GAA  TGA  CTT GGA TAC AGA  CA, reverse GCT CAT TGT TGT ACT  GGT 
TGG ATA  TG),  GABPA  (forward CCA AGC ACA  TTA  CGA  CCA  TTT, reverse CCG 
TGG ACC AGC GTA  TAG GA),  TFAM (forward CCG AAG TGT TTT TCC AGC  AT, 
reverse CAG GGC TGC AAT  TTT CCT  AA), ERRα (forward AGC AAG CCC CGA  TGG 
A, reverse GAG  AAG CCT GGG  ATG  CTC TT),  Cyt c  (forward GCA  AGC ATA  AGA 
CTG GAC CAA  A,  reverse TTG TTG GCA  TCT GTG TAA  GAG AAT  C),  ATPSyn 
(forward AGG CCC TTT  GCC AAG CTT, reverse TTC TCC TTA  GAT  GCA  GCA  GAG 
TAC A), Ndufb5  (forward TTT TCT CAC GCG GAG CTT TC, reverse ATA  AAG  AAG 
GCT TGA  CGA  CAA ACA), COX5  (forward GCT GCA  TCT GTG AAG  AGG  ACA AC, 
reverse CAG CTT GTA  ATG GGT  TCC ACA  GT),  MCAD (forward AAC ACT TAC TAT 
GCC TCG ATT GCA,  reverse CCA  TAG CCT CCG  AAA  ATC TGA  A), Cpt1b  (forward 
ATC ATG TAT CGC  CGC AAA  CT,  reverse CCA TCT GGT  AGG  AGC ACA  TGG), 
GLUT1  (forward CGA GGG ACA GCC GAT GTG, reverse TGC CGA CCC TCT TCT 
TTC  AT),  GLUT4  (forward GAT  GAG AAA  CGG AAG TTG GAG AGA,  reverse GCA 
CCA  CTG  CGA  TGA TCA  GA), GYS1  (forward GAA  CGC AGT GCT TTT CGA  GG, 
reverse CCA  GAT  AGT AGT  TGT  CAC CCC  AT), PDH (forward GAA  GGC CCT GCA 
TTC  AAC TTC, reverse ATA  GGG  ACA  TCA GCA CCA  GTG A), LDH  (forward GGA 
AGG AGG TTC ACA  AGC AG,  reverse TCA  CAA  CAT CCG AGA  TTC CA),  MyHCI 
(forward CCT TGG  CAC CAA  TGT  CCC GGC TC,  reverse GAA GCG CAA TGC AGA 
GTC GGT  G), MyHCIIa  (forward ATG AGC TCC GAC GCC GAG, reverse TCT  GTT 
AGC ATG AAC TGG TAG  GCG), MyHCIIx  (forward AAG GAG CAG GAC ACC AGC 
GCC CA, reverse ATC TCT TTG GTC ACT TTC CTG CT), MyHCIIb (forward GTG 
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ATT TCT  CCT  GTC ACC TCT  C, reverse GGA GGA  CCG CAA  GAA CGT  GCT  GA), 
18S rRNA  (forward AGT CCC TGC CCT TTG TAC ACA, reverse CGA  TCC GAG  GGC 
CTC ACT A),  TBP (forward GGC  CTC TCA  GAA  GCA  TCA CTA, reverse GCC AAG 
CCC TGA  GCA AA). Western  blots were performed on protein extracts from  C2C12 
cells. Antibodies were purchased from  Santa  Cruz (PGC-1α, MCAD) and Cell 
Signaling (Cycs, tubulin), respectively.
Lactate determination
Circulating lactate concentration  in  venous blood was measured 4  h  and 3  days after 
exercise in  the acute and the chronic exercise group,  respectively. Lactate  analysis 
was performed using a  Biosen  C_line (EKF-diagnostic,  Barleben-Magdeburg, 
Germany).
Statistical analysis
Results are presented as mean while error bars depict standard deviation (SD). 
Unpaired, two-tailed student’s t test was performed, statistical significance was 
defined as P < 0.05 and indicated by an asterisk. Eight mice per group, except for 
the trained cohort with seven animals, or three independent cell experiments were 
used.
Results
Electric pulse stimulation of C2C12 mouse muscle cells induces 
PGC-1α gene expression
Several different  protocols for  electric  pulse stimulation  (EPS) of muscle cells in 
culture have been proposed (e.g. see refs. [Fujita et al. 2007, Marotta et al. 2004, 
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Nedachi et  al.  2008, 2009,  Park  et  al. 2008, Silveira  et  al.  2006]).  However, none of 
these approaches included a broad investigation  of the transcriptional adaptations 
associated with  an  active muscle fibre. We thus tested two different  EPS conditions 
and studied three different cell systems to establish stimulation  conditions that 
recapitulate plastic changes on  the gene expression  level.  As a  marker  for a trained 
muscle, we measured the relative expression of PGC-1α,  a  transcriptional coactivator 
that  is regulated by  endurance exercise in  muscle and in  turn  controls many  of the 
muscle adaptations to physical  activity  (Finck and Kelly  2006,  Handschin 2009, 
Handschin  and Spiegelman  2006,  Lin  et al. 2005). For that purpose,  differentiated 
C2C12  myotubes were either stimulated for  90  min  (“acute”,  Fig.  3.1A  and D), for 90 
min  daily  on  4  consecutive days (“intermittent”, Fig.  3.1B and E) or  for  24  h 
(“continuous”, Fig.  3.1C).  The cells were harvested 3  h  after  the EPS and the relative 
expression  of PGC-1α  was quantified by  real-time PCR.  A  single  stimulation  for  90 
min  failed to alter  PGC-1α expression  significantly  (Fig. 3.1A).  In contrast,  repeated 
EPS for  90 min  daily  on  4  consecutive days significantly  induced PGC-1α gene 
expression  (2.4  fold,  Fig. 3.1B).  Finally, a  single EPS for 24  h  resulted in  the highest 
induction of PGC-1α transcript  levels (2.9  fold,  Fig.  3.1C). Silveira  and colleagues 
(2006) demonstrated an enhanced reactive oxygen  species (ROS) production  in 
EPS-treated primary  muscle  cells and postulated an  important role for  elevated ROS 
levels in  the induction  of PGC-1α in these cells. We therefore studied if EPS of C2C12 
cells in  serum-free and hence antioxidant-reduced conditions exacerbates PGC-1α 
induction.  However, elevation  of PGC-1α gene transcription was lower  using serum-
free compared to standard differentiation media  (Fig. 3.1D,  2.1  fold) or  did not reach 
statistical significance (Fig. 3.1E). When  stimulated for  24  h  in  serum-free 
conditions, C2C12  cells changed in  morphology  and adhesion and therefore,  gene 
expression  changes were not  assessed for  this condition. The discrepancies between 
the previously  reported findings and our  data could be explained by  the different 
culture conditions and cell  types that were used in  the previous study  (primary  rat 
muscle cells, ref. [Silveira  et  al.  2006])  and in  the present  work  (C2C12  muscle cells). 
To include additional mouse muscle culture models in our  experiments,  we tested 
the response of SOL8  cells, a myogenic cell  line derived from  mouse soleus  primary 
cells, to the different  EPS regimes and culture conditions.  However, none of our 
stimulation protocols elicited a  significant  change in  PGC-1α mRNA  expression 
(data  not shown). Whether this is due to the origin  of SOL8  cells that  were isolated 
from  soleus, a  muscle that  shows a  very  modest  response to endurance exercise, is 
unclear. Moreover, primary mouse muscle myotubes were overly sensitive to our 
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EPS conditions and did not survive the respective experiments (data  not  shown).  As 
a  consequence of these tests, we used C2C12  cells and the 24  h  EPS paradigm  in  all 
subsequent experiments.
Improved exercise performance of mice after 6 weeks of 
endurance training
Health  benefits of exercise are primarily  associated with  training  whereas a  single 
exercise bout is insufficient  to induce the same effects. To be able to compare the 
transcriptional changes of stimulated C2C12  cells in  culture to those in  acutely 
exercised and trained muscle, we designed an exercise protocol for  mice that 
iteratively  adjusts the training load to the increased muscle function over  6  weeks 
(Fig.  3.2A).  This trained mouse cohort was then  compared to a  group of mice that 
underwent  one endurance trial (called “mice, acute exercise”) and to control mice 
that  remained sedentary, respectively. The endurance trial and the training  bouts 
consisted of treadmill running with incremental  speed (Fig.  3.2B),  either  to 
complete exhaustion for the trials or  to 75% of the distance of the last  exhaustion 
test  for  the training. In  order  to achieve a clear  distinction between  the acute effects 
of exercise and the chronic adaptations, the acute group was sacrificed 4  h  after the 
trial when  blood lactate levels were still  elevated (Fig.  3.2C). In  contrast,  the trained 
group was analysed 3  days after  their  last  bout  of exercise indicating an  absence of 
confounding  effects of the last  acute exercise. At  this time, the mice had normalised 
blood lactate (Fig. 3.2C). The improvement  of endurance exercise capacity  in  the 
trained animals was documented by  significant  increases in  time on  the treadmill, 
distance, work and power after 6 weeks of training (Fig. 3.2D-G).
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Figure 3.1: Electric pulse stimulation  (EPS) of C2C12  myotubes induces PGC-1α gene 
expression. Differentiated C2C12  myotubes were electrically  stimulated for  90  min 
(acute EPS, panels A  and D),  4  consecutive days, 90  min  each  day  (4  days,  sporadic 
EPS, panels B and E)  or for  24  h  (24  h,  chronic EPS,  panel C). These experiments 
were either  performed in  regular  differentiation  medium  (panels A, B and C) or  in 
serum-free conditions with  BSA  (serum-free, panels D and E).  Three hours after 
EPS, cells were harvested, RNA  isolated and the relative expression of PGC-1α 
determined by  real-time PCR.  Bars are average levels of three independent 
experiments and error bars depict  SD. *P < 0.05. Abbreviations: EPS, electric  pulse 
stimulation.
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Figure 3.2: Endurance improvement of chronically  exercised mice.  A, After 
familiarisation, mice were trained for  6  weeks and sacrificed 3  days after  the last 
bout of exercise. This cohort (“chronic exercise”) was compared to a  group of mice 
that  performed one exercise  trial (“acute exercise”) and sedentary  controls.  B,  An 
exercise protocol with  incremental speed was chosen for  the endurance trial  and the 
daily  training.  C, Blood lactate measurement  in  mice after  an  acute bout  of exercise 
(4  h  post  exercise) and after  3  days of recovery. D-G, Endurance running 
performance of mice before (pre-exercise) and after  (chronic exercise)  the 6  week 
training: running  time (panel D), distance (panel E),  work (panel F) and power 
(panel  G). Bars are average levels and error  bars depict  SD. N= 8  animals per  group 
pre-exercise and n=7  animals per  group for  the chronic  exercise (one mouse died 
during the training period). *P < 0.05.
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Induction of mitochondrial regulators and genes by EPS
Endurance training results in  an  improvement of mitochondrial function  and 
oxidative metabolism  (Chow  et al.  2007,  Coffey  and Hawley  2007,  Flueck 2006, 
Flueck and Hoppeler  2003, Hood et  al. 2006). We thus tested how  EPS of C2C12 
cells affected some of the regulators of these processes and genes encoding  oxidative 
phosphorylation  (OXPHOS)  proteins. In  addition to PGC-1α, the GA-binding 
protein  A  (GABPA, alternatively  called nuclear  respiratory  factor  2a  or NRF2a),  the 
mitochondrial transcription  factor  A  (TFAM) and the estrogen-related receptor  α 
(ERRα, NR3B1) were transcriptionally  induced in  stimulated cells compared to 
controls (2.9, 1.5,  1.5  and 1.8  fold,  respectively, Fig.  3.3A).  A  similar  expression 
pattern  was observed in trained mice where PGC-1α was elevated 2.0  fold, GABPA 
3.4  fold,  TFAM 2.8  fold and ERRα 1.8  fold (Fig.  3.3B).  In  contrast,  only  PGC-1α 
transcription  was significantly  increased in  acutely  exercised animals (3.6  fold,  Fig. 
3.3C). ERRα,  GABPA  and TFAM regulate the transcription  of nuclear- and 
mitochondrial-encoded mitochondrial genes, respectively  (Scarpulla  2008). PGC-1α 
coactivates ERRα and GABPA and thereby  greatly  enhances the transcriptional 
activity  of these proteins (Handschin  et al.  2007, Huss et al.  2004, Mootha  et  al. 
2004,  Schreiber  et al. 2004). Finally, the PGC-1α gene itself and those encoding 
these three transcription  factors are transcriptional targets for  the PGC-1α  protein 
(Wu  et  al.  1999,  Mootha  et  al.  2004, Handschin  et  al.  2003,  Schreiber  et  al. 2003). 
As a  consequence of this biological switch,  OXPHOS and other  mitochondrial genes 
are induced.  Accordingly,  EPS-treated C2C12  myotubes expressed higher  levels of 
cytochrome c  (Cyt  c,  1.5  fold, Fig.  3.3D),  ATP synthase subunit  5o (ATPSyn,  1.5  fold), 
NADH-ubiquinone oxidoreductase 1β subcomplex  5  (Ndufb5, 1.6  fold) and 
cytochrome c oxidase subunit  5b (COX5,  1.7  fold).  In  mice that were trained for  6 
weeks, only  cytochrome c and NADH-ubiquinone oxidoreductase 1β  subcomplex 5 
expression  levels were significantly  altered compared to sedentary  control animals 
(3.0 and 2.0 fold,  respectively, Fig.  3.3E).  Four  hours after  an  acute bout  of exercise, 
none of these OXPHOS genes were significantly modulated in muscle (Fig. 3.3F).
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Figure 3.3: Electric  pulse stimulation of C2C12  myotubes induces mitochondrial 
regulators and OXPHOS genes. A, D, C2C12  myotubes were EPS-stimulated for  24 
consecutive hours.  Three hours after  stimulation,  cells were harvested,  RNA 
prepared and relative gene expression  quantified by  real-time PCR. The transcript 
levels were compared to unstimulated control cells. B,  E, Mice were trained for  6 
weeks. The animals were sacrificed 3  days after  the last  exercise bout,  RNA  isolated 
from  gastrocnemius  and relative gene expression  determined by  real-time PCR. 
Transcriptional induction  was compared to the gene expression in  sedentary  control 
mice. C, F,  Mice underwent  one endurance trial  and sacrificed 4  h  later.  RNA  was 
isolated, relative gene expression quantified by real-time PCR and compared to that 
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of sedentary  control mice.  Bars are average levels and error  bars depict SD. The data 
of the C2C12  study  are from  three independent  experiments.  In  the animal  studies, 
n= 8  animals per  group were used except  for  the chronic exercise  cohort with  n=7. 
*P < 0.05. Abbreviations: PGC-1α,  peroxisome proliferator-activated receptor  γ 
coactivator  1α; GABPA,  GA-binding  protein; TFAM,  mitochondrial transcription 
factor  A; ERRα,  estrogen-related receptor  α; Cyt  c,  cytochrome c; ATPSyn,  ATP 
synthase subunit 5o; Ndufb5, NADH-ubiquinone oxidoreductase 1β subunit  5; 
COX5, cytochrome c oxidase subunit 5b; EPS, electric pulse stimulation.
Increased gene expression for substrate uptake and utilisation in 
exercised muscle cells and trained muscle
The increase in  mitochondrial OXPHOS genes in  endurance-trained muscle allows a 
greater  oxidative metabolism  of substrates, both  of glucose and fatty  acids 
(Holloway  2009, Corpeleijn  et  al. 2009).  Accordingly,  we studied some of the genes 
encoding  for  key  enzymes in  substrate import  and usage. Fatty  acid β-oxidation is 
primarily  regulated by  the import  of fatty  acids into mitochondria. This step is 
mediated by  the carnitine-palmitoyltransferase 1b (Cpt1b) in muscle (Consitt et al. 
2009,  Holloway  2009). In the mitochondrial matrix, several  proteins contribute to 
fatty  acid oxidation,  including the medium  chain acyl-CoA  dehydrogenase (MCAD) 
(Consitt et  al. 2009,  Holloway  2009). Cpt-1b and MCAD expression  was elevated in 
EPS-treated C2C12  myotubes compared to untreated cells (Fig. 3.4A,  1.9  fold and 1.4 
fold,  respectively). A  similar  increase in  MCAD and Cpt1b  expression  was observed 
in  trained mice (Fig. 3.4B,  1.8 and 2.3  fold,  respectively)  whereas no change in 
transcription  was seen in  acutely  exercised animals (Fig.  3.4C).  These data  indicate 
that  EPS of muscle cells in  culture triggers an  increase in  fatty  acid β-oxidation 
resembling the adaptations of this pathway in chronic endurance exercise.
In  addition  to fatty  acids,  trained fibres import and use more glucose than untrained 
muscle fibres (Richter  and Ruderman  2009, Santos et  al. 2008). GLUT1  and GLUT4 
are the major  glucose transporters on  the skeletal  muscle cell  membrane (Ebeling  et 
al.  1998). In  the myocyte, glucose is primarily  stored in  the form  of glycogen  or 
alternatively channelled into the glycolytic pathway (Ebeling et al. 1998). 
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Subsequent  to the glycolytic  conversion to pyruvate, glucose is either  metabolised to 
acetyl-CoA by  the pyruvate dehydrogenase and fed into the Krebs cycle in  the 
mitochondria  for  oxidative metabolism  or  reduced to lactate under  anaerobic 
conditions by  the lactate dehydrogenase. In order  to gain insights about  glucose 
metabolism  in  EPS-treated cells,  we measured the expression  of GLUT1, GLUT4, 
glycogen  synthase 1  (GYS1),  pyruvate dehydrogenase (PDH) and lactate 
dehydrogenase (LDH). In  stimulated myotubes,  GLUT1  (2.2  fold),  GLUT4  (3.2  fold), 
glycogen  synthase 1  (1.6  fold) and pyruvate dehydrogenase (1.8 fold) transcription 
were significantly  elevated (Fig.  3.4D). In  contrast,  lactate dehydrogenase 
expression  was unchanged (Fig.  3.4D). This gene expression  pattern  resembles that 
of trained mice where GLUT1  (3.0 fold), glycogen synthase 1  (3.6  fold)  and pyruvate 
dehydrogenase (2.3  fold) were significantly  induced (Fig.  3.4E).  GLUT4  and lactate 
dehydrogenase gene expression  changes failed to reach  statistical significance (Fig. 
3.4E).  In  contrast,  none of the transcripts were altered in  acutely  exercised animals 
(Fig.  3.4F).  In  summary,  our findings imply  an  increased import and oxidative 
metabolism  of glucose as well as an  elevated glycogen  synthesis in  EPS-treated 
C2C12 myotubes similar to the changes in trained muscle.
Altered expression of myosin heavy chain isoforms in stimulated 
muscle cells
Skeletal muscle plasticity  following endurance exercise extends beyond metabolic 
gene expression.  For  example,  a close  association  between oxidative capacity  and the 
levels of the myosin  heavy  chains I and IIA has been reported (Pette and Staron 
2000, 2001, Staron  1997).  These oxidative,  high  endurance muscle fibres are 
classified as type I and IIA  fibres (Pette and Staron 2000,  2001, Staron 1997).  In 
contrast,  the type IIX and IIB muscle fibres are characterised by  a  fast twitching  that 
generates a  high  force and express the myosin heavy  chain  isoforms IIX  and IIB 
(Pette and Staron 2000,  2001,  Staron  1997).  We studied if our  EPS protocol can 
induce expression  changes of genes other  than  those that are directly  involved in 
substrate metabolism  and therefore quantified the relative transcript  levels of the 
four  main  myosin  heavy  chain  isoforms expressed in  the adult  muscle.  These 
experiments revealed a  significant  elevation  of the expression  of myosin  heavy  chain 
I (MyHCI, 1.7 fold) and myosin heavy chain IIX (MyHCIIx, 2.0 fold), whereas 
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transcription  of myosin  heavy  chain  IIA  and IIB (MyHCIIa  and MyHCIIb) was 
unchanged (Fig.  3.5A).  Our  chronic exercise paradigm  elicited similar  changes in 
vivo.  In  these mice,  myosin  heavy  chains I and IIX  transcript levels were 
upregulated (2.4  and 1.9  fold, respectively) while the expression of myosin  heavy 
chains IIA  and IIB was unchanged (Fig. 5B). In  muscle tissue of acute exercise mice, 
none of the myosin  heavy  chains exhibited altered expression  levels (Fig.  3.5C). 
Thus, EPS of C2C12  myotubes triggered a  modulation of myofibrillar  gene 
expression resembling that of trained muscle.
Changes in protein levels in EPS-treated C2C12 myotubes
The relative changes in  transcript levels and those observed for  the respective 
protein  can differ  significantly, Thus,  to test  whether  the EPS treatment  of C2C12 
myotubes also alters protein  levels in  addition  to the induction  in  gene expression, 
we performed Western blots using  antibodies for  a  selection  of the genes that were 
analysed by  real-time PCR (Fig. 3.6).  We observed higher  protein  levels for  PGC-1α, 
cytochrome c  (Cycs)  and the medium  chain  acyl-CoA dehydrogenase (MCAD) (Fig. 
3.6) that  reflect  the higher  transcript levels of the respective genes (Fig.  3.3A,  3.3D 
and 3.4A, respectively).
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Figure 3.4: Electric pulse stimulation  of C2C12  myotubes modulates fatty  acid and 
glucose metabolism.  A, D, C2C12  myotubes were EPS-stimulated for  24  consecutive 
hours.  Three hours after  stimulation, cells were harvested,  RNA  prepared and 
relative gene expression  quantified by  real-time PCR. The transcript levels were 
compared to unstimulated control cells. B,  E,  Mice were trained for 6  weeks. The 
animals were sacrificed 3  days after the last  exercise bout, RNA  isolated from 
gastrocnemius and relative gene expression determined by  real-time PCR. 
Transcriptional induction was compared to the gene expression in sedentary control 
mice. C, F,  Mice underwent  one endurance trial  and sacrificed 4  h  later.  RNA  was 
isolated, relative gene expression  quantified by  real-time PCR and compared to that 
of sedentary control mice. Bars are average levels and error bars depict SD. The data 
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of the C2C12  study  are from  three independent  experiments.  In  the animal  studies, 
n= 8  animals per  group were used except  for  the chronic exercise  cohort with  n=7. 
*P < 0.05. Abbreviations: MCAD,  medium  chain acyl-CoA  dehydrogenase; Cpt1b, 
carnitine palmitoyltransferase 1b; GLUT1,  glucose transporter  1; GLUT4,  glucose 
transporter  4; GYS1, glycogen  synthase 1; PDH,  pyruvate dehydrogenase; LDH, 
lactate dehydrogenase; EPS, electric pulse stimulation.
Figure 3.5: Electric  pulse  stimulation  of C2C12  myotubes alters the myosin  heavy 
chain  expression  patterns.  A, C2C12  myotubes were EPS-stimulated for  24 
consecutive hours.  Three hours after  stimulation,  cells were harvested,  RNA 
prepared and relative gene expression  quantified by  real-time PCR. The transcript 
levels were compared to unstimulated control cells. B, Mice were trained for  6 
weeks. The animals were sacrificed 3  days after  the last  exercise bout,  RNA  isolated 
from  gastrocnemius  and relative gene expression  determined by  real-time PCR. 
Transcriptional induction  was compared to the gene expression in  sedentary  control 
mice. C, Mice underwent one endurance trial and sacrificed 4 h later. RNA was 
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isolated, relative gene expression  quantified by  real-time PCR and compared to that 
of sedentary  control mice.  Bars are average levels and error  bars depict SD. The data 
of the C2C12  study  are from  three independent  experiments.  In  the animal  studies, 
n= 8  animals per  group were used except  for  the chronic exercise  cohort with  n=7. 
*P < 0.05.  Abbreviations: MyHCI, myosin heavy  chain I; MyHCIIa,  myosin  heavy 
chain  IIa;  MyHCIIx, myosin  heavy  chain IIx; MyHCIIb, myosin  heavy  chain IIb; 
EPS, electric pulse stimulation.
Figure 3.6: Elevation  of protein levels in  EPS-treated C2C12  myotubes. Protein 
extracts of control and EPS-treated C2C12  myotubes were analyzed in  Western  blots 
for  the expression  of PGC-1α,  cytochrome c (Cycs),  medium  chain acyl-CoA 
dehydrogenase (MCAD) and tubulin.
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Discussion
Exercise  results in  extensive adaptations in  skeletal  muscle and other  organs (Booth 
and Lees 2007, Flueck  and Hoppeler  2003, Handschin  and Spiegelman  2008).  Due 
to this complexity,  our understanding of the molecular  processes in  these plastic 
changes is rudimentary.  Furthermore,  experimentally  amenable model systems for 
exercise remain  elusive. In  this report,  we describe how  a  cell culture model can be 
established to study  at  least some of the gene expression changes in  the trained 
muscle. We found that key  genes in metabolic processes,  substrate uptake and 
oxidation  are regulated by  EPS in  these cells. The pattern of gene expression 
qualitatively  resembles very  closely  that  of trained,  but not acutely  exercised muscle. 
Importantly,  adaptation of muscle to training confers health  benefits much  more 
than the acute changes following a single bout of exercise.
Our  analysis centered on the expression and function of the coactivator  PGC-1α. 
This gene is central to the adaptations of muscle to exercise by  transcriptionally 
regulating  this biological  programme. Upon  ectopic expression with  viral vectors, 
PGC-1α  induces and coactivates some of its binding partners (Mootha  et  al. 2004). 
Here, we demonstrate that  EPS-triggered elevation of PGC-1α  is likewise sufficient 
to increase the levels of these transcription  factors and subsequently,  of 
mitochondrial OXPHOS genes. Moreover, the relative expression  levels of genes 
encoding  fatty  acid import and β-oxidation  proteins and those involved in  glucose 
uptake and conversion  of pyruvate  to acetyl-CoA suggest  that concomitant  with  an 
elevated mitochondrial function,  substrate availability  and metabolism  are increased 
in  EPS-treated C2C12  cells and trained muscle. Finally,  the elevated expression  of 
the glycogen  synthase in  EPS-treated cells mirrors that  of glycogen synthase in 
exercise in vivo.  In the  latter, augmented glycogen  synthesis helps to replenish  and 
expand the glycogen  storage in  trained muscle (Ivy  1991, Nielsen and Richter  2003). 
Thus, the gene expression pattern  in  EPS-treated C2C12  myotubes suggests an 
extensive metabolic remodelling as found in trained muscle.
In vitro exercise system  59
While  the metabolic gene expression  determines substrate usage,  other  muscle fibre 
parameters, such  as fibre contraction  speed and peak force generation,  are 
controlled by  myofibrillar  proteins. The respective gene expression  of the myosin 
heavy  chain  isoforms is used to classify  the fibres into different fibre-types 
(Spangenburg  and Booth  2003).  The relative proportion  of these fibre-types is to a 
large extent  regulated by  the motor  neuron  input  (Thomas and Ranatunga  1993), 
although  additional  factors including genetic  predisposition and imprinting exist 
(Hoh  1991, Huang  et  al.  2006,  Partridge 2005).  The lack of innervation  of muscle 
cells in  culture is likely  to contribute to the poorly  attributable fibre-type of many 
muscle cell  lines.  Electric  stimulation can at least  partially  substitute for  the missing 
motor neurons. We have observed an increase in  the expression  of specific  myosin 
heavy  chains in  EPS-treated C2C12  myotubes. Our  data  suggest that with  an 
adjusted protocol,  e.g.  slow, continuous stimulation  or  fast,  sporadic stimulation, 
certain fibre-types can be promoted in  these cells in  culture.  Moreover, in 
combination  with  other  approaches such  as addition  of slow  or  fast  muscle extracts 
(Matsuoka  and Inoue 2008) or  continuous mild heat  stress (Yamaguchi  et  al. 2010), 
EPS of muscle cells in culture might be used to study fibre-type-specific properties.
Some of the previous studies on  EPS in  muscle cells in  culture indicated that serum-
free conditions might be better  in  inducing  exercise-like adaptations compared to 
cells that  are cultured with  serum  (Silveira  et al. 2006).  It is possible that  the 
elevated levels in  reactive oxygen species in  serum-free medium  contributes to EPS-
mediated induction  of muscle gene expression  (Silveira  et  al.  2006).  Interestingly, a 
similar  negative effect  of administration  of large doses of antioxidant  vitamins on 
exercise performance in  humans has been  shown (Ristow  et al.  2009).  In  our 
experiments, no significant difference between serum-containing  and serum-free 
conditions was observed,  which  could be explained by  differences in  culture and EPS 
conditions. Nevertheless,  these findings indicate that  EPS-treated C2C12  cells might 
be used to study  the effects of reactive oxygen  species and antioxidants, respectively, 
on  muscle in  exercise. Moreover, it  might  be interesting  to use a  known  composite 
serum  for  these experiments,  which  then  can  be supplemented with  additional 
factors and study their effect on exercise-like adaptation.
In  summary,  we have established an  experimental  protocol to qualitatively  simulate 
some of the exercise-induced changes in  gene expression in  muscle  cells in culture, 
at least for the genes that were included in the study. Clearly, a single bout of 
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stimulation of cell in  culture does not reflect  the complexity  and time-dependent 
adaptation  of skeletal muscle  to exercise in vivo.  Besides the missing  neuronal 
activation, other  stimuli of training adaptation,  e.g.  the hormonal milieu,  are 
missing.  Second,  the determination  of protein  levels, enzymatic activates and 
functional read-outs might  differ  between the cells in  culture and muscle in vivo.  We 
tested some of the proteins for  which  increased gene expression  was observed in  the 
EPS-treatment  and found elevated protein  levels for  PGC-1α,  Cycs and MCAD (Fig. 
3.6). In any  case, such  an  experimental system  allows the delineation  of molecular 
mechanisms important for  the contracting  muscle fibre that  cannot be performed in 
muscle in vivo.  In  the future,  this model system  will  have to be adapted and refined. 
In  particular, combining EPS with  mechanical stretch  or  temporary  hypoxia  might 
further  help to approximate the environment  that  a  fibre of a  trained muscle is 
exposed to. Similarly,  co-cultures of motor neurons with these muscle cells might 
improve the comparability  of the culture systems with  muscle in vivo.  These 
interventions might increase the activation  of the different signalling  pathways that 
converge on  PGC-1α in  the exercised muscle (Handschin  2010) and thereby  further 
improve this cell culture model  system.  This will be tested by  quantifying  the 
activation  of these pathways,  e.g.,  phosphorylation  of the AMP-dependent protein 
kinase and its cellular  targets.  Ultimately,  these cells might constitute a  key  tool to 
further  elucidate the molecular  mechanisms of muscle adaptation to activity  and 
inactivity and test novel approaches to treat fibre atrophy and muscular dystrophies.
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Introduction
Exercise  is a  general term  used to describe activities involving  generation  of force by 
the activated muscle(s)  that  results in  disruption  of a  homeostatic  state (Winter  and 
Fowler  2009).  In  the traditional view  exercise can  be classified as either  "resistance" 
or  "endurance".  In  humans, the outcomes of resistance exercise include increases in 
maximal muscle power, skeletal  muscle mass, and muscle fibre cross-sectional area 
(CSA) (Tesch  1988) with  little  or  no increases in maximal  oxygen  consumption 
(Gettman et  al. 1978) or  the overall  capillary-to-fibre ratio (Campos et  al. 2002, 
Tesch  1988). Conversely,  endurance exercise leads to increases in  maximal oxygen 
consumption,  maximal cardiac output, and time to exhaustion  at  submaximal  power 
(Holloszy  and Coyle  1984).  Endurance exercise also increases muscle mitochondrial 
biogenesis,  oxidative enzymes,  and capillarisation.  However, it does not  increase 
maximal muscle power  or  mediate muscle hypertrophy  (Holloszy  and Coyle 1984). 
There are also adaptations that are common  to both  exercise modalities,  namely  the 
directional changes in  myosin  heavy  chain (MYH)  fibre type expression  after 
prolonged training from 2X to 2A (Spangenburg and Booth 2003). 
Whole body  vibration  exercise is a  recent  exercise modality  that  is largely  unknown 
to the scientific community  relative to classical strength and endurance exercise 
regimens,  despite its popularity  amongst  exercisers and patients. The literature 
suggests that  for  sports training  vibration exercise is an effective method to increase 
jump height in  a  shorter  time than  conventional resistance exercise (Rittweger 
2010). The increase in  jump height  is correlated with  an  increase in maximal knee 
extension or  jumping  power,  and this increase in maximal  power  is correlated with 
an  increase in muscle mass (Rittweger  2010). These effects can  be potentiated when 
resistance exercise is added on top of vibration exercise (Rittweger 2010).
Notably, resistance and endurance exercise cannot be performed simultaneously 
(i.e.  on  top of each  other), but instead each  exercise modality  has been 
supplemented with superimposed blood flow restriction to potentiate its training 
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effects and broaden  its fields of application. The combination  of low-load [20-50% 1-
repetition maximum  (1-RM)] resistance exercise with  blood flow  restriction  results 
in  gains in torque and hypertrophy  that are commensurate with  traditional high-
load (> 70% 1-RM) exercise (Burgomaster  et  al. 2003, Takarada  et  al.  2002, 
Takarada  et  al.  2000). This process also promotes fatigue resistance,  as measured by 
an  increased end-test torque after  50 maximal isokinetic  leg  extensions (Takarada et 
al.  2002). On  the other  hand,  1-legged cycling exercise (45  min  per  session,  4 
sessions per  week for 4  weeks)  with  50 mmHg (6.67  kPa) external pressure over  the 
working  leg  can  increase oxidative enzyme activity, capillarisation, maximal oxygen 
uptake, endurance capacity, and glycogen  storage compared with  non-ischemic 
training of same duration  and power  output  (Sundberg  1994). Furthermore,  this 
type of training  reduces maximal isokinetic (ω = 3.14  rad·s−1) torque,  tends to 
increase the proportion  of MYH-1  fibres,  and reduces the  proportion  of MYH-2X 
fibres (Sundberg 1994). 
Taken  together,  the simultaneous combination  of vibration  exercise and resistance 
exercise enhances maximal power, whereas the simultaneous combination of 
resistance exercise  and vascular  occlusion  increases fatigue resistance (i.e.  time to 
exhaustion  at  submaximal  power).  An  unaddressed question  is whether  the 
simultaneous combination  of whole body  vibration, resistance exercise and 
restricted blood flow  (subsequently  termed VRO) will  facilitate a  concurrent increase 
in  maximal (e.g.  during  jumping) and submaximal (e.g. during  cycling)  measures of 
human power output and fatigue resistance. 
The goal of this study  was to determine how  a  5-week VRO training  regime 
influenced the mean response in  maximal jumping  power, maximal isokinetic  (ω = 
3.14  rad·s−1) leg  extension  power,  maximal cycling  power,  time to exhaustion  at 
submaximal (85%) cycling  power,  and end-test torque following  50 maximal 
concentric  isokinetic leg  extensions in  young women. Also myocellular  and cardio-
circulatory  adaptations were assessed to relate functional and cellular/organic 
adaptations. A control  group of young  women  without  exercise were measured over 
the same period to account  for  any  systematic biases in  measurements that might 
occur  during the acquisition  of muscle tissues, tissue processing,  body  composition 
assessment, and functional testing.
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Materials and Methods
Participants
We recruited 21  sedentary  young  women  by  placard and randomly  assigned them  to 
two groups (vibration  exercise + resistance exercise + vascular  occlusion [VRO]: 12 
women; no training  [CON]: 9  women).  Participants in  the VRO group were 23.5 
(3.0) years old. Their  body  mass index was 21.6  (2.6)  kg·m−2,  and maximal  oxygen 
consumption was 2.21  (0.25) l·min−1.  Participants in  the CON group were 24.5  (SD 
3.8)  years old and had a  body  mass index of 21.8 (1.7) kg·m−2,  and their  maximal 
oxygen  consumption was 2.21  (0.48)  l·min−1.  These characteristics were not 
different between  groups.  All  study  participants were healthy. Nine (VRO) and seven 
(CON) women  were taking  oral  contraceptives.  After  completing  a  routine health 
questionnaire, the participants were informed about the procedures applied and 
about  the associated risks.  The participants then  signed an informed consent.  All 
experiments were approved by  the ethics committee  of the canton of Zurich, and the 
study  was performed in  accordance with  the ethical standards laid down  in  the 
Declaration of Helsinki for human experimentation.
Study design and exercise protocol
The study  consisted of 1) pretests; 2) 6  weeks of VRO or  a  similar  period without 
exercise for  CON (5  weeks with  progressively  increasing training  load, last week  with 
unchanged load); and 3) posttests (Fig.  4.1).  This time frame was chosen  because 
substantial and significant gains in  muscle power are consistently  achieved with 
vibration  training intervals of 6  weeks,  after  which  there may  not  be any  further 
improvement  (Rittweger 2010). The employed exercise regimen  is described 
according  to our  previous recommendations (Toigo and Boutellier  2006).  During 
the study, macronutrient intake was not monitored, and participants were not given 
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any food or dietary supplements.
Figure 4.1: Overview  of experimental protocol  on  a  weekly  scale (-2  to 7).  B, biopsy; 
F,  familiarisation  session  with  respect to training and testing; Q, graded cycling 
exercise test; E,  constant-load exercise test; C, dual-energy  X-ray  absorptiometry; M, 
muscle testing  (mechanography  and isokinetic dynamometry); T1-16,  training 
sessions with  progressive training  load; t1-3,  training  sessions with  constant (same as 
during  T16)  training intensity.  VRO, Galileo® vibration  + resistance exercise + 
vascular occlusion.
Pre- and posttests.  Before and after  VRO we performed baseline measurements to 
assess maximal oxygen  consumption, maximal cardiac output,  cycling  endurance 
capacity,  isokinetic leg  extension  fatigue resistance,  training  load,  thigh lean  mass, 
as well  as vastus lateralis  muscle fibre size, fibre phenotype and capillarisation. 
Before  the pretests, participants could familiarise themselves with  the training  and 
testing procedures on two separate occasions. 
Exercise regimen. Participants of the VRO group performed three supervised 
progressive training  sessions per  week on  alternate days (i.e. Monday,  Wednesday, 
Friday)  for  5  weeks (16  training sessions),  followed by  three training  sessions with 
the same load and time under  tension  (TUT)  as during the last  progressive training 
session  (Fig. 4.1). At the beginning  of each  exercise session, participants performed a 
warm-up (3  min), which involved squat  and upright heel  rise movements on  a 
Galileo® side-alternating vibration plate (Novotec, Pforzheim, Germany) with 
vibration frequencies ranging from 6-30 Hz using various vibration amplitudes. The 
warm-up was followed by six sets of VRO: loaded (Multipower®, Technogym, 
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Gambettola,  Italy) squats (three sets) and heel  rises (alternating between  two sets of 
upright heel  rises and one set of seated heel rises or  vice versa)  were performed 
while standing  on  the Galileo® (Novotec,  Pforzheim, Germany) oscillating  at  30 Hz. 
A  frequency  of 30 Hz has been shown to be the optimal frequency  for  producing  the 
greatest  magnitude of response in EMG activity  of vastus  lateralis muscle in an 
isometric half-squat  position  (Cardinale and Lim  2003).  Feet  were placed on  the 
center  of the plate with the calcanei 0.28 (0.03)  m  apart  during  squats,  as well as 
0.25  (0.03) and 0.19  (0.03) m  apart  during  upright  and seated heel  rises, 
respectively,  with  toes pointing slightly  outwards. The corresponding vibration 
amplitudes were ∼3·10−3 m  (6·10−3 m  from  top to bottom) for  squats and ∼2·10−3 m 
(4·10−3 m  from  top to bottom) for  heel rises. Participants wore skid-proof socks to 
eliminate any damping of the vibration which could have been caused by footwear. 
For  both, squat and heel  rise exercises (three sets each), a  duty  cycle of 4  min  on 
(maximal tolerable limit) and 1  min  off was employed.  Participants rested for  5  min 
between squats and heel rises. Three sets per muscle group were chosen in order to 
attain  occlusion  times (i.e.  12  min  per  session) that were in-between of those 
previously  published (Pierce et al.  2006, Reeves et  al. 2006). Vascular  occlusion 
during  the on phase of the duty  cycles was induced by  inflating  tourniquet  cuffs 
(thigh: width 0.09  m, length  0.76  m; calf: width  0.075  m, length  0.46  m; VBM, Sulz 
a.N.,  Germany) affixed to the inguinal  fold region  of the thigh,  or  to the proximal 
portion  of the lower  leg, centered in  the space between the superior  aspect  of the 
gastrocnemius  muscle and the inferior  edge of the patella  to suprasystolic  pressure, 
i.e. 197  (3) mmHg  [26.26  (0.40) kPa]. The suprasystolic  pressure employed here was 
the highest pressure that was tolerated by  the participants for  the duration  of the on 
phase of the duty  cycles (4  min  each).  For  both, squat and heel rise exercises, 
tourniquet  cuffs were inflated right  before the first  set and remained inflated until 
the 4  min of vascular  occlusion were complete. The cuffs were then deflated to a 
pressure of 100 mmHg  (13.33  kPa),  and the participants rested for  1  min before the 
cuffs were quickly  reinflated for  the subsequent  set. Right upon cuff inflation, 
Galileo® vibration was initiated in parallel with squat or heel rise exercise. 
Load magnitude was adjusted from  prior  knowledge (familiarisation  sessions) in 
order  to induce volitional failure within  40-60 s of exercise.  Loads were adjusted 
progressively during the training period, i.e. in every training session either TUT or 
load magnitude were increased (2.5-5.0 kg). Load magnitudes (including the 4.5 kg 
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barbell  and the plate loading mass)  during  the first  training  session  corresponded to 
57.5  (16.0)  and 61.7  (21.1)  %  body  mass for  the first  set  of squat and upright heel rise 
exercise,  respectively. For squat sets two and three the loads were reduced by  10.0 
(4.0) and 15.9  (6.5) % body  mass. Load reduction  was 6.8 (4.1)  %  body  mass for  heel 
rise sets two and three. At  the onset  of squat exercise, participants grasped the 
loaded barbell,  which was locked on  the supports at shoulder  height,  with  their 
hands spaced slightly  more than  shoulder  width  apart. Subsequently, they  released 
the barbell  with  a twist of their  wrists, positioned it  on  the back  of their  necks,  and 
initiated squatting by bending their knees and flexing the hip. 
One repetition  comprised squatting  over  the individual's maximal range of motion 
(ROM), usually  from  near  complete extension  to a  knee angle of slightly  less than 
90° in  4  s (eccentric  action) and back to near  complete extension  in  4  s (concentric 
action). Transition  from  eccentric  to concentric  action  was performed smoothly 
within  1-2  s.  Thus,  TUT  for  one repetition  was 9-10  s, allowing  four  to six  repetitions 
per  set. Squat  ROM in  terms of vertical displacement  of the barbell along  the guide 
rod of the barbell  support  was 0.72  (0.05)  m. Volitional exhaustion  (task failure)  was 
defined as the point in  time where the participants failed to extend their  legs.  Safety 
stops along the guide rod were set  to allow  for  safe and full  range exercise to 
volitional  exhaustion.  Participants were advised to breathe as smoothly  as possible. 
Exercise  form  and functional anatomy  were always controlled by  the same training 
supervisor, and whenever  necessary  the participants were  corrected in real  time. At 
task failure,  the training supervisor stopped vibration and helped the participants to 
adopt  an upright posture.  Subsequently, the participants stood still  on  both  feet 
(body  mass symmetrically  distributed) for 3  min  while the inflated tourniquet cuffs 
were still on.  Afterwards, cuffs were deflated to a  pressure of 100 mmHg (13.33  kPa) 
for  1  min  before they  were reinflated for  the next  set.  Heel rise exercise was 
performed analogous to squat exercise. 
Experimental procedures
Muscle biopsy analyses.  During the pre- and posttesting  period of time, we obtained 
a  percutaneous biopsy  [average tissue mass per  biopsy: 20.3  (3.1) mg] after  local 
anaesthesia with 1% lidocaine from the middle portion of the nondominant vastus 
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lateralis  muscle,  using  a  ProMag Ultra  device and 14  gauge needles (Angiotech 
Pharmaceuticals, Gainesville,  FL, USA), as previously  described (Walti  et al.  2006)). 
After  removal,  the muscle  tissue was immediately  mounted in an  embedding 
medium  (Tissue-Tek®, Sakura, Zoeterwoude, The Netherlands), snap frozen in 
isopentane cooled to −160 °C with  liquid nitrogen, and subsequently  stored at  −80 
°C  until  use.  Consecutive 12  µm  sections were cut  on  a microtome at  −25  °C and 
mounted on  glass cover  slides for  further histochemical and immunohistochemical 
analyses.  For  all  fibre analyses, only  fibres fully  encircled by  adjacent fibres were 
evaluated.  Measurements were made for  at least  50  of each  of the main  fibre types 
(i.e.  MYH isoform  type 1  and 2).  Previous studies investigating  the skeletal  muscle 
fibre sample size required for  a reliable,  valid representation  of an  individual's 
average fibre area  and capillary-to-fibre ratio showed that 50 fibre measurements 
per  individual  for  type 1  and 2  fibres and capillary  contacts are sufficient  to 
characterise type 1  and 2  fibre areas and capillary-to-fibre ratio of an  individual 
(McCall et  al.  1998,  Porter  et al.  2002). We stained the serial  cryocut cross-sections 
using  the myofibrillar  adenosinetriphosphatase (mATPase)  method after  acid (pH 
4.3  and 4.6) and alkali (pH 10.5) preincubation according  to Guth  and Samaha 
(1970), with  minor  modifications (Muentener  1979).  Subsequently,  we classified the 
muscle fibres according  to their  MYH isoform  into MYH-1  and MYH-2,  measured 
the muscle fibres' diameter by  the lesser  fibre diameter-method (Dubowitz and 
Sewry  2007), and estimated fibre CSA  from  the lesser  diameter  assuming  the fibres 
to be circular. Composition  of MYH type 1  and type 2  fibres was determined from 
ATPase stains. 
For  the analysis of oxidative enzyme activity  we incubated consecutive sections in 
media  containing  cytochrome c oxidase. For  the determination of muscle 
capillarisation, we fixed consecutive cryocut sections with  acetone for 10  min  at 4  °C 
and exposed them  to the monoclonal  mouse anti-human CD31  endothelial cell 
antibody  (DAKO, Carpinteria,  Canada,  1:600  dilution),  which  acts as a  marker  for 
muscle capillarisation.  We performed this staining  procedure using the 
Vectastain®  ABC Kit  (Vector  Laboratories, Burlingame, Canada), according  to the 
manufacturer’s instructions. For  the control  samples, we replaced the antibody  with 
Tris-buffered saline (TBS) buffer. Overall capillary-to-fibre ratio was calculated by 
dividing the number  of CD31-positive  cells by  the number  of muscle fibres.  Images 
were captured by an optical widefield microscope (Polyvar, Reichert-Jung, Vienna, 
Austria) with a connected digital camera (Leica DFC 420 C, Wetzlar, Germany)
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under the same microscope objective (10×).  For  all  histochemical and immuno-
histochemical analyses,  we used the NIH Image J software (version  1.41o, National 
Institutes of Health,  Bethesda, MD, USA).  Arbitrary  cytochrome c  enzyme activity 
levels were derived from  the measured mean  optical density  pixel values of the 
muscle fibres normalised to the background pixel values on the same section. 
Dual-energy X-ray absorptiometry  (DXA).  We used DXA  (Lunar  iDXA™, GE 
Healthcare,  Madison, WI,  USA)  to determine the lean  mass of both  thighs.  Scans 
were conducted in the standard mode (0.13-0.25  m) according  to the manufacturer’s 
specifications. We used the GE encore software version  11.40.004  to delineate the 
regions of interest (ROI, i.e. thigh) as follows: ROI upper  boundary  = line through 
the femoral neck parallel  to the inguinal  ligament; lower  boundary  = horizontal line 
between femur and tibia; lateral boundaries = outer leg cuts. 
Oral glucose tolerance test.  A  standard glucose tolerance test  (OGTT) was 
performed in  the morning  after  an  overnight fast.  Participants ingested 75  g of 
glucose in  300  ml water. Venous blood samples were drawn  two times just before 
and at  30,  60,  90,  and 120 min  after  ingestion  of glucose for  determining  plasma 
glucose, serum insulin, and C-petide.
Blood analysis. Venous blood samples were collected in  EDTA,  separated,  and 
stored at  −20°C before being assayed. Plasma glucose concentrations were deter-
mined by  an automated hexokinase  method (HK,  Unit-Kit  III, Roche, Basel,  Switzer-
land)  and serum  insulin  concentrations were determined by  radioimmunoassay 
(Insulin ct-kit, Cisbio Bioassays, Bagnols-sur-Cèze Cedex, France). Haemoglobin A1c 
(HbA1c) was immunochemically  measured with the DXC 2000®  device (Bayer, 
Leverkusen, Germany).  The high  sensitivity  c-reactive protein  (hsCRP) was assessed 
with  the Immulite 2500 kit  (Siemens, Siemens Medical Solution  Diagnostics,  Los 
Angeles,  USA),  triglyceride,  high-density  lipoprotein  (HDL),  and cholesterol  were 
analysed using  commercial tests from  Roche Diagnostics GmbH (Basel, 
Switzerland). Insulin  sensitivity  was estimated by  the homeostasis model 
assessment (HOMA-IR) and calculated as: HOMA-IR = {[fasting  insulin  (µU·ml
−1)]·[fasting glucose (mmol·l−1)]}·22.5−1.
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Training. Training loads and number  of completed repetitions (9-10  s of TUT  per 
repetition,  as described before)  were continuously  recorded.  Training  performance 
was retrospectively  assessed by  comparing loads and repetitions for  the first  set  of 
VRO squat exercise between the first and last  progressive training session.  These 
measures were chosen  because 1-repetition maximum  testing  is not applicable to 
VRO. During  the third and last  training  session,  we continuously  recorded heart  rate 
(S610i, Polar  Electro, Kempele, Finland), and measured blood lactate concentration 
by  drawing  20 µl of arterialised venous blood from  an earlobe at rest, after  the squat 
routine,  after  the heel  rise routine,  and 10-15  min  after exercise.  Blood samples were 
analysed enzymatically  amperometrically  with  a BIOSEN C_line Sport® (EKF-
diagnostic,  Barleben, Germany). In  addition,  we assessed perceived exertion  and 
perceived pain  after  the third squat and heel rise duty  cycle using  a  visual analogue 
scale (VAS).  The VAS scale consisted of a  horizontal line.  The word “none”  was 
placed at  the  left  end of the scale,  and “very  severe”  was placed at the right  end of the 
scale.  The VAS was scored from  0  to 10,  but  the participants were unaware of the 
numbers. 
Isokinetic  dynamometry. We tested maximal knee extension  power and fatigue 
resistance of the nondominant leg  using  a  commercially  available dynamometer 
(Con-Trex MJ,  CMV, Dubendorf,  Switzerland). The inclination of the backrest  was 
set  to an  angle of 85°.  The dominant leg  was fixed at a  knee angle of 90° and body 
posture was stabilised using  straps and handles. The individual maximal ROM was 
determined during  the pretests and also used for  posttests.  Before the tests, the 
participants performed 20 warm-up movements,  alternating  between knee 
extensions and flexions of varying submaximal effort  and angular  velocity.  Warm-up 
was followed by  two maximal knee extensions (ω = 3.14  rad·s−1), separated by  1  min, 
to assess maximal power. Subsequently,  a  fatigue test  consisting of 50 alternate 
maximal voluntary  knee extensions and knee flexions (ω = 3.14  rad·s−1) was 
performed to assess end-test  leg  extension  torque (mean  value over  the last  five 
repetitions)  and to calculate fatigue percentage [(mean torque value of the first  five 
maximal repetitions − end-test  torque)/(mean torque value of the first  5  maximal 
repetitions) ·100]. 
Jumping mechanography. Three vertical  countermovement jumps with  freely 
moving  arms (separated by  30 s of rest)  were performed on  a  strain  gauge ground 
reaction force platform (Leonardo®, Novotec, Pforzheim, Germany) linked to a 
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desktop computer  using an  integrated analog  digital  board and software  system 
(Leonardo® GRFP Mechanography  version  4.2, Novotec, Pforzheim,  Germany).  The 
participants were instructed to remove their  shoes, stand with  feet  shoulder width 
apart  and arms hanging loosely  at  their  sides.  They  were further  instructed to jump 
as high  as possible while keeping their  head still during  the flight of the jump, and to 
stand still  again with  arms hanging  loosely  after  landing. The maximum  jump height 
was calculated as the highest  displacement  of the center  of mass, and the relative 
maximal power  was calculated from  the product  of force and velocity.  From  the 
three valid attempts,  the jump with  the highest  jump height  was used for further 
analyses.
Graded cycling exercise tests. We used Innocor™ (Innovision,  Odense,  Denmark) to 
determine maximal cardiac  output by  inert gas rebreathing, oxygen  consumption 
and ventilation  by  breath-by-breath  ergospirometry,  as well as arterial oxygen 
saturation and heart  rate during a  GXT as previously  described (Fontana  et  al. 
2009).  Participants rested in  the seated position  on  the cycle ergometer for  2  min, 
and afterwards started cycling  at  50  W  with  a  self-selected pedal  rate (≥ 70 
revolutions·min−1). This pedal rate was consistently  (± 5  revolutions·min−1)  applied 
throughout the test.  Power  was increased by  25  W  every  2  min  until volitional 
exhaustion, i.e. the point in  time at  which  the participants stopped cycling  or  were 
no longer  able to maintain  pedal rate within  the required limits. Maximal cardiac 
output  was determined immediately  before exhaustion,  and arterio-venous oxygen 
difference was calculated according  to the Fick  principle.  Ventilatory  threshold was 
determined as the power  corresponding  with  a  disproportionate increase in  minute 
ventilation. In  addition,  we assessed rate of perceived exertion  using  a  modified 
Borg scale from 0 to 10 at rest, at the end of each stage, and at exhaustion.
Constant-load cycling exercise tests.  We used a  constant-load cycling  exercise test 
(CLT)  to assess time to exhaustion  at  submaximal power  as an  indicator  of 
endurance capacity. Power  of the initial warm-up stage was 40%  maximal power of 
the first  GXT. After  1  min, we increased power  to 60% peak  power  (for  2  min)  and 
then  to 85% maximal power.  Power  at  85% maximal power  was sustained until 
volitional  exhaustion,  i.e. the point  in  time at  which  the participants stopped 
pedalling or were no longer able to maintain pedal rate within the required limits.
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Statistical analyses. We report  all  group data  as mean (SD).  A paired sample t-test 
was used to compare intra-group differences.  To assess between-group effects we 
analysed the differences between  pre- and posttraining  values using  student’s t-test 
for  2  independent  samples. Equality  of variances was checked using  Levene’s test. 
We used SPSS 16.0  statistical software (SPSS,  Chicago,  USA) for  all statistical 
analyses, and statistical significance was set at P < 0.05.
Results
Training
Maximal heart  rate achieved during  VRO was 94.1  and 91.4  % of maximal heart  rate 
during  GXT for  pre- and posttraining  measurements, respectively  (Fig. 4.2A). The 
corresponding values for maximal blood lactate concentration were 77.3 and 75.4% 
(Fig.  4.2B). Perceived exertion  and pain  were high  and did not  change over  time, 
indicating that participants exercised with  maximum  voluntary  effort  (Fig.  4.2C). 
Perceived exertion  during  VRO was similar  to maximal exercise during  GXT  to 
exhaustion, in  which  perceived exertion  was rated 9.7  (0.9) and 9.5  (1.2) on  a 
modified Borg scale for  pre- and postmeasurements,  respectively. During  the period 
of time between  the first  (occurring  in  week  1) and last  (occurring  in  week 6) 
progressive training  session,  VRO participants increased the training load by  84.5%, 
while the number  of repetitions (and as such  TUT) until volitional failure was the 
same at both points in time (Fig. 4.2D). 
Muscle (fibre) size, metabolism, and capillarisation
VRO resulted in  a 16.7  and 13.8% increase in  vastus  lateralis  muscle fibre CSA  for 
MYH type 1  and 2  fibres,  respectively  (Fig. 4.3A,  B).  However,  a  testing  time by 
group interaction  was observed only  for  MYH-1  fibre hypertrophy  (P = 0.019), 
demonstrating that VRO increased MYH-1 fibre CSA relative to CON. Concordantly, 
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thigh  lean  mass increased by  4% in  the VRO group [VRO: 10.6  vs. 11.0 kg  (P = 
0.001); CON: 10.7  vs. 10.7  (P = 0.972); testing  time by  group interaction: P = 0.008] 
(Fig. 4.3C). Notably, MYH-1 fibre proportion and overall capillary-to-fibre ratio were 
increased by  14.0% each  (Fig.  4.3D). Furthermore, the increase in  cytochrome c 
oxidase activity  reflecting the shift  in  the MYH-1  and MYH-2  fibres' metabolic 
phenotype towards the oxidative phenotype was only  observed in  VRO (Fig. 4.3E, 
F).
Figure 4.2: Peak heart  rate (A) and blood lactate concentration  (B) during  VRO 
compared to the maximal values obtained during the graded cycling  exercise test 
(GXT) at the beginning and end of the study. Perceived exertion  and pain  during  the 
3rd VRO squat set  at  the beginning  and end of the study  (C).  Training  load and 
number  of repetitions (9-10 s per  repetition) during the first  squat  set  of the first 
and last  training  session  (D).  Bars and error  bars represent  mean  values and 
standard deviations, respectively,  for  the 12  women undergoing  VRO.  VRO,  Galileo® 
vibration  + resistance exercise + vascular  occlusion.  ***,  significantly  different  first 
vs. last training session at P < 0.001.
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Submaximal and maximal power, time to exhaustion, and end-test 
torque
Maximal power  during  GXT was increased by  8.7% in  VRO relative to CON (Fig. 
4.4A).  VRO also increased time to exhaustion during  CLT  and ventilatory  threshold 
(GXT) by  57.0  and 11.7%,  respectively  (Fig.  4.4B,C), relative to CON. Additionally, 
VRO improved concentric isokinetic  leg  extension fatigue resistance by  15%  (Fig. 
4.4D),  while neither  maximal concentric  isokinetic knee extension power nor 
maximal jumping power per  kg body  mass was increased after  VRO (Fig. 4.4E, F). 
Body  mass remained unchanged for  both  groups [VRO: 60.9  (8.1) vs.  61.1  (8.0),  P = 
0.680; CON: 60.7 (5.4) vs. 60.7 (5.6), P = 1.000].
Cardiac output, oxygen consumption, and ventilation 
VRO increased maximal cardiac  output  (albeit  without  significant  testing  time by 
group interaction) (Tab. 4.1), while no change in  maximal oxygen  consumption, 
calculated arterio-venous oxygen  difference, or  arterial oxygen  saturation  was 
observed for  either  group.  Higher  maximal power  in VRO had no effect  on 
ventilation, while a  lower  maximal power  correlated with  a  reduction  in  ventilation 
in CON (Tab. 4.1).
Exercise induced PGC-1α and VEGF expression 76
Figure 4.3: Muscle fibre cross-sectional  area  (CSA) for myosin  heavy  chain  type 1  (A) 
and 2  (B)  fibres,  overall capillary-to-fibre ratio (C), myosin  heavy  chain  type 1  fibre 
percentage (D),  and cytochrome c (cyt  c) oxidase activity  in  optical arbitrary  units 
(AU) for  type 1  (E)  and 2  (F) fibres pre- and posttraining.  Bars and error  bars 
represent  mean values and standard deviations,  respectively,  for: (A) and (B),  eight 
women  per  group; (C), seven  women per  group; (D),  six  and five women  in  VRO and 
CON,  respectively;  (E)  and (F),  eight and seven  women  in  VRO and CON, 
respectively.  VRO, Galileo® vibration + resistance exercise + vascular  occlusion; 
CON,  control  group.  *,**,  ***,  significantly  different within  group pre vs.  post,  *P < 
0.05, **P < 0.01, ***P < 0.001; †,  pre vs.  post differences significantly  different 
between groups at P < 0.05.
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Table 4.1:  Maximal values for  cardiac output, oxygen  consumption,  and ventilation 
during  the graded exercise test.  Values are means (SD) for 12  women  (VRO) and 
nine women  (CON). VRO,  Galileo® vibration  + resistance exercise + vascular 
occlusion; CON,  control group. *P < 0.05,  **P < 0.01; †, pre vs.  post differences 
significantly different between groups at P < 0.05.
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Figure 4.4: Maximal power  during the graded cycling exercise test  (GXT, A),  time to 
exhaustion  during  a  constant-load cycling exercise test  (CLT,  B),  ventilatory 
threshold calculated based on  gas exchange during  GXT  (C),  knee extension  (KE) 
fatigue following  50  repeated maximal concentric  isokinetic  (ω = 3.14  rad·s−1) knee 
extensions (D), maximal concentric isokinetic knee extension power  (E), and 
maximal countermovement jump (CMJ) power  per kg  body  mass (F)  pre- and 
posttraining.  Bars and error  bars represent  mean  values and standard deviations, 
respectively,  for: (A),  (B),  (C), and (F), 12  and nine women in VRO and CON, 
respectively;  (D) and (E), 10  and seven  women  in  VRO and CON, respectively.  VRO, 
Galileo® vibration  + resistance exercise + vascular occlusion;.  VRO, synthetic 
exercise group; CON, control group. *, **, ***, significantly  different pre vs. post 
within  group,  *P < 0.05,  **P < 0.01, ***P < 0.001; ††, †††,  pre vs. post  differences 
significantly different between groups, ††P < 0.01, †††P < 0.001.
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Body composition
VRO resulted in  a  2.0 and 4.5% increase in  total  body  and leg lean  masses, 
respectively  (Tab. 2.2). However,  a testing time by  group interaction was observed 
only  for total leg lean  mass (P = 0.001),  indicating  that VRO increased leg  lean  mass 
relative to CON. Concordantly,  total  body  fat mass and relative body  fat  decreased 
solely  after  VRO,  with  a  group interaction  in relative body  fat  (P = 0.035) (Tab.  2.2). 
These changes in body composition led to an unaffected total body mass (Tab. 2.2).
Table 2.2: Body composition of study participants
Values are means (SD) for  12  women  (VRO) and nine women  (CON). VRO,  Galileo® 
vibration  + resistance exercise + vascular  occlusion; CON, control group. *,**, ***, 
significantly  different  within  group pre vs. post,  *P < 0.05,  **P < 0.01, ***P < 0.001; 
†,††,†††, pre vs.  post  differences significantly  different between groups at †P < 0.05, 
††P < 0.01, †††P < 0.001.
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Cardiometabolic risk factors
Cardiometabolic risk  factors such  as waist-to-hip ratio, blood pressure, blood lipid 
levels,  glycaemic  status,  calculated insulin  resistance, and blood glucose 
concentration  in  the fasting state as well as after  the ingestion of glucose were 
unaffected after both training regimens, VRO and RES, respectively (Tab. 2.3).
Table 2.3: Cardiometabolic risk factors of study participants
Values are means (SD). VRO, Galileo® vibration  + resistance exercise + vascular 
occlusion; CON,  control group; HDL-C,  high-density  lipoprotein  cholesterol; total-C, 
total cholesterol; hsCRP, high-sensitive c-reactive protein; HbA1c,  glycosylated 
haemoglobin  A1c; HOMA-IR,  homeostasis model assessment, calculated insulin 
resistance; OGTT,  oral glucose tolerance test; AUC,  area  under  the curve. 
Significantly different within group pre vs. post, *P < 0.05.
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Discussion
This study  showed that  5  weeks of VRO significantly  increased the maximal cycling 
power, time to exhaustion  at  submaximal cycling  power,  and end-test torque after 
50  maximal concentric isokinetic (ω = 3.14  rad·s−1) leg extensions in young women. 
However,  VRO had no effect  on their  maximal jumping  and concentric isokinetic  leg 
extension power. Increased endurance capacity  was commensurate with  increased 
vastus lateralis  muscle MYH-1  fibre proportion  and hypertrophy,  oxidative 
enzymes,  and overall capillarisation,  while maximal  oxygen  consumption  and 
cardiac output  remained unchanged. Despite the increased total body  and leg  lean 
masses after  VRO, no changes in  cardiometabolic  risk  factors were observed. Our 
results demonstrate that VRO is an  effective training  modality  to rapidly  increase 
submaximal power  capacity  in  young women.  Furthermore, given  that  the vastus 
lateralis  muscle adaptations were achieved with  a  minimal of 3  × 3  min  of thigh 
muscle activity per week, time efficiency of VRO was high. 
VRO is a  training  modality  which  required maximum  effort  from  participants. This 
was evident from  the high  ratings of perceived exertion and pain, the high  peak 
blood lactate concentration, and the high  peak heart  rate.  In  return,  training  time 
commitment  for  VRO was substantially  lower  (by  as much as 90%) relative to 
classical endurance exercise.  The increase in  VRO training  load for  squats was 
substantial.  It  increased by  85%  in  5  weeks, which  corresponds to a  15  percentage 
points higher  value than  that  previously  reported for  the increase (approximately 
70% within  5  weeks of training)  in  squat 1-RM during the early  phase of heavy-
resistance training  in  young women  (Staron  et al.  1994,  calculated from  Fig.  4.2C). 
The increase in  training  load during  VRO was linear, with  70% of the overall  gain 
occurring  within  the first 20  (of 35)  days of training  (data not  shown).  To our 
knowledge, there are no reports about the time course of squat  training  load 
adaptation  in  young  women  during  the first 5  weeks of training.  However,  in  young 
men  undergoing  flywheel resistance training, investigators have found that 
approximately 65% of the increase occurs within the first 10 (of 35) days of training 
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(Seynnes et al.  2007).  Therefore, the increase in  training  load during  the early  phase 
(first  10 days)  of VRO apparently  was less steep relative to classical resistance 
exercise,  but it was steeper for  the remainder  of the training duration  (35  days). The 
observed time course thus suggests that  neural  adaptations and gains in  muscle CSA 
following  VRO might  be different in  nature and/or  time course of manifestation 
relative to classical resistance exercise. 
The increase in  training  load following VRO correlated with  increases in  muscle 
fibre CSA.  It is widely  accepted that  resistive exercise can increase the CSA  of both, 
type 1  and 2  fibres.  For  example, it  has been shown  that CSA  of type 1  and 2A (but 
not 2X) fibres in  the vastus lateralis  muscle of young  women  increases by  20  and 
19%, respectively, after  9  weeks of high-resistance exercise, using  a  protocol  which 
requires an individual  to perform  50 unilateral leg  extension repetitions at near-
maximal effort  per  session  for  3  sessions per  week (i.e. 150  near-maximal repetitions 
per  week,  Martel et  al.  2006).  In  comparison, VRO increased CSA  of type 1  and 2 
fibres to a  similar  extent  (17  and 14%  for  type 1  and 2  fibres, respectively) in 
approximately  half the time, and with  a  training  volume that  was approximately  2/3 
lower  (18  repetitions per  session  for  3  session per  week, i.e. 54  repetitions per  week). 
However,  only  MYH-1  fibre hypertrophy  was significant between  groups over  time 
(Fig.  4.3A, B), indicating that  5  weeks of VRO preferentially  promoted type 1  fibre 
hypertrophy. There are also reports of greater  increases in  CSA  for  all  fibre  types, as 
determined in  vastus  lateralis  muscle biopsy  samples from  young women after  6 
weeks of high-resistance exercise (Staron  et  al. 1991).  However,  in  that  study  3 
different exercise modes comprising  both  open- (leg  extension) and closed-chain 
(squat  and leg  press) actions were employed to induce hypertrophy.  This might 
facilitate the detection  of a  higher  number  of size-enlarged fibres in  the sampled 
muscle tissues because of the increased motor  unit  recruitment  coverage (and 
consequently  the number  of stimulated vastus  lateralis  muscle fibres) during 
training relative to squat  exercise only. Notably, VRO mediated a  fast  adaptation  in 
muscle fibre CSA, considering  that  even  in  the case of high-resistance exercise with 
different exercise modes (open- and closed-chain)  and larger  training  volume, 
increases in  CSA  of vastus lateralis  muscle  fibres in  young  women usually  require at 
least 6-8 weeks of training (Staron et al. 1994, Staron et al. 1991). 
DXA  thigh  lean  mass increased by  approximately  4% in  5  weeks (Tab. 2.2),  lending 
further credence to our finding that VRO induced muscle fibre hypertrophy. Other 
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investigators have recently  found that  12  weeks (5  training sessions per  week)  of 
heavy, whole-body  resistance exercise, consisting  of a rotating  multiset  and 
multimode split  routine targeting  all major  muscle groups,  leads to an  approximate 
5% increase in  total  body  lean  mass in  young  women supplementing  their  diets with 
0.5  l  fat-free milk  immediately  post and 1  h  post  exercise (2  times 0.5  l) (Josse et al. 
2010,  calculated from  Fig.  2). In  contrast,  women consuming  isoenergetic 
carbohydrate instead of protein  increased total  body  lean mass by  only  2.5% (Josse 
et al. 2010, calculated from  Fig.  2).  Similarly, in  elderly  men and women a 2.9% 
increase in  DXA-derived thigh  muscle mass was found following  resistance exercise 
requiring  an  individual  to perform  135  leg  extensions 3  times per  week  for  10 weeks 
(i.e.  405  repetitions per  week,  4050 repetitions in  total,  Delmonico et  al.  2008). 
Hence, assuming  that  segmental  training-induced increases in  DXA  muscle mass are 
proportional to total lean mass increases after  whole-body  exercise, an  increase of 
2.5-3.0% in  DXA thigh  muscle mass can be expected after 10-12  weeks of high-
resistance exercise when  the participants' diets are not supplemented with  protein  in 
the postexercise period. Our  finding that the participants undergoing  VRO increased 
thigh  lean mass by  4% in  half the time without  supplementing protein  and 
furthermore using a  training volume which  can be up to 15  times smaller  (i.e.  270 vs. 
4050  repetitions) indicates that  VRO may  lead to an  increased net muscle protein 
balance relative to classical resistance exercise.  However, changes in  DXA  lean  mass 
should be interpreted with  caution,  because DXA  technology  cannot discriminate 
between  the various components (water, protein,  glycogen, and minerals) within  the 
lean soft tissue.
Increases in  training  load and muscle fibre CSA  are generalised findings for  training 
modalities involving  high-load (> 70% 1-RM) resistance or low-load (20−50% 1-RM) 
resistance combined with  blood flow  restriction.  As a  novel  and specific feature, 
VRO concurrently  increased MYH-1  fibre proportion, overall capillary-to-fibre ratio, 
and oxidative enzyme activity.  The finding that  VRO increased MYH-1  fibre 
proportion is of special  interest,  since the only  conversion  of pure fibre types 
following  endurance and/or  resistance exercise in  humans that  is well  documented 
is conversion  of type 2X to type 2A, and thus it is not  believed that  type 2  fibres can 
be converted to type 1 fibres with classical training (Spangenburg and Booth 2003). 
Whereas capillarisation  can  increase after  weeks or  months of moderate to vigorous 
endurance training in humans (Andersen and Henriksson 1977), high-resistance 
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exercise usually  decreases capillary  density, presumably  as a  result of fibre 
hypertrophy  in  the absence of angiogenesis (Egginton 2009). Specifically, in  young 
women  both  the overall  capillary-to-fibre ratio and the capillary  density  are not 
influenced even  after  18 weeks of resistance exercise (Wang  et  al. 1993). Similar  to 
the adaptation  in  capillarisation, increases in  mitochondrial enzyme levels and 
respiratory  capacity  are common  adaptations to endurance exercise  (Holloszy  and 
Coyle  1984) but  generally  remain unaffected in  response to resistance-type exercise 
(Tesch 1988). 
Taken  together,  VRO concurrently  induced muscular  adaptations that  typically  are 
mediated by  either  high-resistance (muscle hypertrophy) or  endurance exercise 
(capillarisation, oxidative enzymes).  In  addition, like 1-legged cycling  exercise (45 
min  per  session, four  sessions per  week  for  4  weeks) with  50 mmHg (6.67  kPa) 
external  pressure over  the working leg  (Sundberg 1994) VRO increased the 
proportion of MYH-1  fibres. These cellular/organic changes were paralleled by  an 
increase in  critical torque, as shown by  the increased end-test torque following  50 
consecutive maximal  isokinetic  (ω  = 3.14  rad·s−1)  knee extensions. End-test  torque 
has been  shown to correlate with  the estimated critical  torque (Burnley  2009), 
which  in turn has been suggested to be analogous to the critical  power for  cycling 
exercise (Burnley  2009,  Jones et  al.  2010).  Our  finding  that  end-test  torque was 
increased by  15% after  VRO is consistent with  those of Eiken  et  al.  (1991) and 
Takarada  et  al. (2002) who found that isokinetic  (ω = 3.14  rad·s−1) end-test torque is 
increased by  13  and 7.6  % after  a  period of ischaemic  1-legged cycling  exercise and 
low-resistance exercise with  vascular  occlusion,  respectively. Consistent with  the 
notion that  dynamometry-derived critical  torque is analogous to critical power  for 
cycling exercise,  both  the increase in  ventilatory  threshold and the markedly  (+ 57%) 
increased time to exhaustion during a  CLT  could be explained by  an  increase in 
critical power  in this study. Notably, we found that  endurance capacity  could be 
increased without  concurrently  increasing maximal  oxygen  consumption, 
supporting  the conclusion  of other  authors that the percentage change in 
submaximal performance is not  associated with  the percentage change in  maximal 
oxygen  consumption  (Vollaard et  al.  2009).  In  contrast  to the marked increases in 
the capability  of participant  to generate and sustain  submaximal power,  maximal 
power  remained unchanged, as shown  by  the similar  values for  maximum  voluntary 
isokinetic  (ω = 3.14  rad·s−1) leg  extension  power  and jumping power  normalised to 
body mass (body mass remained unchanged). This finding contrasts the current 
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notion that vibration  exercise alone or in  combination with  resistance exercise 
increases knee extension  and jumping power (Rittweger  2010), and points towards a 
distinct  role for  vascular  occlusion. The fact  that  maximal  concentric  isokinetic  (ω = 
3.14  rad·s−1) leg  extension  power  remained unchanged after VRO indicates that 
muscle force also remained constant  (power  = force · velocity). Unchanged muscle 
force can  be explained by  a concurrent  increase in  MYH-1  fibre CSA  and proportion 
after  VRO.  In  fact,  the increase in  maximal concentric isokinetic force due to an 
increase in the number  of parallel sarcomeres within  MYH-1  fibres might  have been 
blunted by  the concurrent  increase in  the share of the muscle CSA  consisting  of 
MYH-1  fibres,  because MYH-1  fibres have reduced isometric maximal tension 
(Linari  et al. 2004) relative to MYH-2  fibres. Moreover,  MYH-1  fibres display  lower 
maximal shortening velocity  and power  than  MYH-2  fibres (Linari et  al.  2004). 
Thus, despite the higher  MYH-1  fibre power due to hypertrophy,  mixed muscle 
maximal shortening velocity  might be reduced,  possibly  explaining  the unchanged 
maximal jumping  power  after  VRO. Similarly,  Eiken et  al. (1991) found that  the 
increase in  MYH-1  fibre proportion  after  ischaemic training  (notably  without 
concurrent  fibre hypertrophy) was paralleled by  a  decreased maximal isokinetic  (ω = 
3.14  rad·s−1) leg extension  torque.  They  concluded that blood flow-restricted 
training,  in  contrast  to non-restricted-flow  training, decreases maximum  torque 
because of an increase in  the share of the muscle CSA  consisting  of MYH-1  fibres. In 
our  study,  fibre hypertrophy  might have prevented the drop in  maximal power 
otherwise caused in the case of a sole increase in MYH-1 fibre proportion. 
Despite the increase in  total body  and leg lean  masses by  2.0  and 4.5% and the 
decrease in  total fat  mass by  3.2% after  VRO, no changes in  various cardiometabolic 
risk factors were observed (Tab.  2.2  and 2.3).  All  study  participants were healthy 
and asymptomatic  without a  cardiometabolic risk  factor  clustering  (Wildman  et  al. 
2008). The mechanism  how  physical activity  influences cardiometabolic risk  factors 
is only  partially  understood.  It  has been  suggested that glucose uptake after 
endurance and resistance exercise training  can  occur  with and without  changes in 
total lean mass and body  composition  (Poehlman et al.  2000).  Based on the fact, 
that  VRO was consisted of a  very  short-time training invervention,  our  data  indicate 
that  not  solely  the skeletal muscle mass makes a  major impact  on  cardiometabolic 
risk factors but that  the time under  which  skeletal  muscles are under  tension is more 
important.
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In  summary, 5  weeks of VRO concurrently  increased GXT power,  CLT time to 
exhaustion, ventilatory  threshold and end-test  torque. These increases were related 
to increases in  MYH-1  fibre hypertrophy  and proportion, muscle capillarisation, and 
oxidative enzymes,  but  not  maximal oxygen  consumption  and cardiac  output. 
Conversely, VRO had no effect  on maximal isokinetic  leg  extension  and jumping 
power, probably  due to the competing  effects of MYH-1  fibre hypertrophy  and 
increased MYH-1  fibre proportion on  maximal  mixed muscle tension  and velocity. 
We conclude that  VRO is an effective and time efficient  (vastus lateralis  muscle 
adaptations were achieved with  a  minimal of 3  × 3  min  of thigh muscle activity  per 
week)  training  modality  to quickly  increase the capacity  to generate and sustain 
submaximal power in young women.
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Introduction
Endurance exercise is a  powerful inducer  of mitochondrial biogenesis and 
angiogenesis in  human  skeletal muscle (Coffey  and Hawley  2007). Mitochondrial 
biogenesis involves the coordinated expression  of the mitochondrial genome and the 
nuclear  genes that  encode mitochondrial proteins (Hood 2001), while  angiogenesis 
requires the coordinated action  of numerous signals involved in  vessel formation 
and maturation (Carmeliet 2000). One transcriptional regulator  that  can  orchestrate 
both  signals required for  mitochondrial  biogenesis and angiogenesis is peroxisome 
proliferator-activated receptor γ  coactivator  1α (PGC-1α) (Arany  et  al. 2008,  Geng et 
al.  2010, Puigserver  and Spiegelman 2003,  St-Pierre et  al.  2003,  Wu  et al.  1999). 
PGC-1α  docks on  and coactivates the nuclear  respiratory  factors 1  and 2α  (NRF1  and 
NRF2α) (Wu  et al.  1999).  These transcription  factors regulate the expression  of 
nuclear  genes encoding  mitochondrial proteins (Scarpulla  2002) and induce the 
expression  of mitochondrial transcription  factor  A  (Tfam) (Wu et  al. 1999). PGC-1α 
also activates the transcription factor  estrogen-related receptor  α (ERRα),  which 
elicits a robust  induction  of vascular  endothelial growth factor  (VEGF) in  cultured 
muscle cells and mouse skeletal muscle in vivo  following  hypoxia  and limb 
ischaemia,  respectively  (Arany  et al. 2008). Arany  et  al.  (2008) concluded that 
PGC-1α  has a  critical function  in  the angiogenic response to ischaemia  and they 
speculated that  the PGC-1α/ERRα pathway  also mediates exercise-induced 
neovascularisation (Arany  et  al. 2008).  Indeed,  it  has recently  been shown  that in 
rodent  skeletal muscle, exercise-induced PGC-1α regulates the vascular  endothelial 
growth  factor  (VEGF) (Chinsomboon et  al.  2009, Geng et  al.  2010).  Notably,  the 
induction of VEGF by  PGC-1α has been  shown to occur  independent  of hypoxia-
inducible factor-1α (HIF-1α) (Arany  et  al.  2008),  which  is a  well-known hypoxia-
induced transcription factor  regulating  VEGF expression (Wenger  2000).  Increased 
PGC-1α  mRNA  expression  after  a  single bout  of endurance exercise is related to 
AMP-activated protein  kinase (AMPK)  activation (Jaeger  et al.  2007), p38  mitogen-
activated protein  kinase activation  (Akimoto et  al. 2005,  Puigserver  et al.  2001), 
calcium signalling (Handschin et al. 2003), and the level of reactive oxygen species 
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(ROS) (St-Pierre et  al.  2006), indicating that  both  metabolic and oxidative stress are 
responsible for the induction of PGC-1α. 
In  Chapter  4,  we reported that 5  weeks of whole-body  vibration  training  with 
superimposed heavy  resistance exercise and sustained vascular  occlusion (VRO) 
increases capillary-to-fibre ratio, skeletal  muscle oxidative enzyme activity, myosin 
heavy  chain  type 1  (MYH-1) fibre proportion,  and endurance capacity. These 
findings were intriguing,  since increases in  oxidative muscle  phenotype and 
endurance capacity  are  typically  induced by  endurance exercise but not  heavy 
resistance exercise (Coffey  and Hawley  2007, Holloszy  and Coyle 1984).  Contrary  to 
classical heavy  resistance exercise,  VRO comprises sustained ischaemia  and 
vibration. These two stimuli  have been  shown  to activate VEGF expression  and 
promote capillarisation  in various settings (Gustafsson  et  al.  1999,  2002, Richardson 
et al.  1999,  Sundberg  1999). We thus hypothesised that  a  single bout of VRO 
activates several genes associated with  mitochondrial biogenesis and angiogenesis. 
To this end, we analysed the acute  effects of VRO on  gene expression  in  comparison 
to traditional heavy resistance exercise.
Design and Methods
Participants
Eight men  of age 23.1  (2.8) years participated in  this study.  They  were all  healthy, 
asymptomatic,  non-smoking,  and recreationally  active. After  completing a  routine 
health  questionnaire  the participants were informed about  the applied procedures 
and the associated risks.  Informed written  consent  was obtained from  all 
participants. The experimental protocol  was approved by  the ethics committee of the 
canton  of Zurich, and the study  was performed in  accordance with  the ethical 
standards laid down in the Declaration of Helsinki for human experimentation.
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Experimental protocol
The study  consisted of a  crossover  design. All subjects performed two different 
exercise protocols,  which  were separated by  2  weeks in  a  randomised order. Before 
the first exercise session,  we performed baseline measurements,  a  familiarisation 
session, and a  baseline biopsy,  each  session  separated by  1  week.  During the baseline 
measurements,  we assessed body  composition and squat  1RM. Participants could 
familiarise themselves with  the experimental model  and the associated procedures 
on  a  separate occasion. Participants were asked to refrain  from  vigorous physical 
activity  for  24  h  prior  to all sessions accomplished in  this study. The evening  (12  h) 
before the baseline biopsy  and exercise sessions, participants were fed a 
standardised meal  consisting  2.96  g  carbohydrate⋅kg−1 body  mass,  0.5  g  protein⋅kg−1 
body mass, and 0.32 g fat⋅kg−1 body mass.
Exercise protocols
VRO. VRO has been  described in  Chapter  4  in  detail.  It was comprised of loaded 
(Multipower®,  Technogym,  Gambettola,  Italy) squats standing  on  a  Galileo® side-
alternating  vibration  plate (Novotec,  Pforzheim, Germany) oscillating  at 30 Hz, and 
superimposed vascular occlusion.  Load magnitude (approximately  70% of the 
individual 1RM) was adjusted from  prior  knowledge (familiarisation) in  order  to 
induce volitional  failure within  60-100 s of exercise.  Volitional  exhaustion  (task 
failure)  was defined as the point  in  time where the participants failed to extend their 
legs.  Vascular  occlusion  was induced by  inflating tourniquet  cuffs (VBM, Sulz a.N., 
Germany) affixed to the inguinal fold region  to the thigh  to approximately  200 
mmHg (26.7  kPa). The suprasystolic  pressure employed here was the highest 
pressure that  was tolerated by  the participants in  this setting. The exercise regimen 
consisted of two sets, each  set  with  a  duty  cycle of 4  min  and 1  min  off.  During  the 
duty  cycle,  participants performed loaded squats with  superimposed whole-body 
vibration  and vascular  occlusion  until  volitional failure.  Subsequently, tourniquet 
cuffs remained inflated until the 4  min  of the duty  cycle were complete.  The cuffs 
were then deflated to a pressure of 100 mmHg (13.3 kPa), and participants rested
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for  1  min  before cuffs were reinflated for  the second set. The load magnitude was 
reduced by  approximately  10% points for  the second set in  order  to keep exercise 
time constant. 
RES.  During  RES, squats were performed without  superimposed vibration  and 
vascular  occlusion, but  while standing  on  the vibration  plate (off).  After  volitional 
exhaustion, participants rested for 4 min standing still until the second set started.
Skeletal muscle biopsies
We obtained percutaneous biopsies from  the middle  region  of the nondominant 
vastus lateralis  muscle at  baseline and 3  h  post exercise using  a  6-mm  Bergstroem 
needle (Dixons Surgical  Instruments, Essex, UK) with  suction applied.  Biopsy 
samples were immediately  frozen  in  liquid nitrogen  and stored at −80°C until 
mRNA  were analysed. Part  of the baseline biopsy  were additionally  mounted in  an 
embedding  medium  (Tissue-Tek®,  Sakura, Zoeterwoude,  The Netherlands) and 
snap frozen in  isopentane cooled to −160°C with  liquid nitrogen  for  subsequent 
immunohistochemical analysis. 
RNA extraction and mRNA analyses
Total RNA  from  vastus  lateralis  muscle samples was extracted by  using the RNeasy 
fibrous tissue minikit  (Qiagen, Basel, Switzerland).  First-strand complementary 
DNA  synthesis was performed with  200 µg  total  RNA  by  using  reverse transcriptase, 
and mRNA  abundance was determined by  real-time quantitative PCR by  using  a 
SybrGreen® qPCR reagent kit  (Sigma, Buchs, Switzerland) in  combination  with  the 
MX3000P light cycler  (Stratagene,  Amsterdam,  The Netherlands). Initial  template 
concentrations of each  sample were calculated by  comparison  with  serial dilutions of 
a  calibrated standard. Equal input levels were verified by  determining ribosomal 
protein  L28  mRNA abundance, and data  were expressed as ratios relative to L28 
mRNA expression. Sequences of the primers are given in Table 5.1.
Exercise induced PGC-1α and VEGF expression 93
Table 5.1: PCR primer sequences for the measured gene transcripts
Skeletal muscle fibre properties
We performed histochemical  analyses as described in  Chapter  4.  In  brief, we stained 
serial cryocut  cross-sections using  the myofibrillar  adenosinetriphosphatase 
(mATPase) method according  to Guth and Samaha  (1970) with  minor  modifications 
(Muentener 1979). We classified muscle fibres according to their  myosin  heavy  chain 
(MYH) isoform  into MYH-1, MYH-2A, and MYH-2X, and measured the muscle 
fibres’  diameters by  the lesser  fibre diameter-method (Dubowitz and Sewry  2007). 
For  all  histochemical  analyses,  we used the NIH Image J software (1.41o,  National 
Institutes of Health, Bethesda, MD, USA).
Dual-energy X-ray absorptiometry (DXA)
We used dual-energy  X-ray  absorptiometry  (Lunar  iDXA™,  GE Healthcare, 
Madison, WI, USA) to determine whole-body  lean  and fat masses according to the 
manufacturer.
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Determination of squat 1RM
1RM measurements comprised squatting  over  the individual’s maximal range of 
motion, usually  from  near  complete extension  to a  knee angle of slightly  less than 
90° in  4  s (eccentric  action) and back to near  complete extension  in  4  s (concentric 
action). Transition  from  eccentric  to concentric  action  was performed smoothly 
within  1-2  s.  The warm-up was followed by  three repetitions at 70% anticipated 
maximum.  Three to five subsequent attempts were made to determine the 1RM, 
with a 5 min rest interval between squats.
Statistical analyses
Data  are presented as mean  (SD). To obtain  normally  distributed data, mRNA copy 
numbers were log-transformed. Comparisons between  groups were performed by 
one-way  analysis of variance (ANOVA).  Differences between  individual means were 
tested for  statistical significance by  t-tests for  dependent samples with  Bonferroni 
adjustment. The level of significance was set  to P < 0.05.  For all  statistical  analyses, 
SPSS 16.0 statistical software (SPSS, Chicago, IL, USA) was used.
Results
Characterisation of study participants
Squat 1RM of study  participants was 121  (18) kg.  A  detailed anthropometric 
description of study  participants is depicted in Table 5.2. For  the histochemical 
analyses a  mean  of 159  (66)  and 122  (54) fibres were counted per  muscle biopsy  for 
determination of fibre types and muscle fibre cross-sectional area, respectively.
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Table 5.2: Anthropometric data of study participants
Data are means (SD). MYH, myosin heavy chain isoform; CSA, cross-sectional area.
Skeletal muscle mRNA analyses
Mitochondrial biogenesis. PGC-1α mRNA  expression  increased significantly  to ∼ 
4.4-fold (P < 0.001)  3  h  after  a  single bout  of VRO. In  contrast,  PGC-1α mRNA 
abundance increased only  ∼ 2.4-fold (P = 0.227) after  RES (Fig.  5.1A) being 
significantly  different from  VRO (P = 0.036). There was no increase observed in 
transcription  factors associated with  mitochondrial biogenesis such as ERRα, NRF1, 
and Tfam after both exercise modalities (Fig. 5.1B, C, and D).
Angiogenesis  and oxygen sensing. VEGF mRNA  abundance was solely  elevated 
after  VRO approximately  twofold (P < 0.001), whereas no increase was observed 
after  RES (P = 0.881,  group difference P < 0.024,  Fig. 5.2A).  No changes were 
detected in HIF-1α and the HIF prolyl hydroxylase 3  (PHD3) mRNA  expression 
after both VRO and RES (Fig. 5.2B and C). 
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Metabolic  key enzymes. HKII mRNA increased 3  h  after  a  single bout of VRO ∼ 2.5-
fold (P = 0.004) but  not  after RES (P = 0.715,  group difference P = 0.020,  Fig.  5.3A). 
mRNA  levels of other  metabolic key  enzymes such  as CS, LDHA, and PFKm  were 
not affected after both exercise modalities (Fig. 5.3B, C, and D)
Oxidative stress.  The mRNA  abundance of XD increased significantly  after  VRO (∼ 
2.3-fold, P = 0.007) but not  after  RES (P = 0.665) with  no group difference (P = 
0.632, Fig. 5.4A). Furthermore,  MnSOD mRNA abundance only  increased after  VRO 
(∼ 1.6-fold,  P = 0.048)  but  not  after  RES (∼ 0.8-fold, P = 0.167) being  significantly 
different from VRO (P = 0.001) (Fig. 5.4B).
Figure 5.1: Alterations in  PGC-1α (A),  ERRα (B), NRF-1  (C), and Tfam  (D) mRNA 
abundances 3  h  after  a  single bout  of RES (grey  bars)  or  VRO (black bars) relative to 
baseline (white bars) levels. Bars and error  bars represent  mean  values and standard 
deviations,  respectively. ERRα, estrogen-related receptor  α NRF-1, nuclear 
respiratory  factor  1; PGC-1α, peroxisome proliferator-activated receptor  coactivator 
1α; RES,  resistance exercise;  Tfam,  mitochondrial  transcription  factor  A; VRO, 
Galileo®  vibration  + resistance exercise + vascular  occlusion. *** significantly 
different from  baseline, P < 0.001; # significantly  different within  exercise modality 
RES vs. VRO, P < 0.05.
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Figure 5.2: Alterations in  VEGF (A),  HIF-1α (B),  and PHD3  (C) mRNA  abundances 3 
h  after  a single bout of RES (grey  bars) or  VRO (black bars)  relative to baseline 
(white bars)  levels. Bars and error  bars represent mean  values and standard 
deviations, respectively.  HIF-1α,  hypoxia-inducible transcription  factor; PHD3, 
prolyl hydroxylase dehydrogenase 3; RES, resistance exercise;  VEGF,  vascular 
endothelial growth factor; VRO,  Galileo®  vibration  + resistance exercise + vascular 
occlusion.  *** significantly  different  from  baseline,  P < 0.001; #  significantly 
different within exercise modality RES vs. VRO, P < 0.05.
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Figure 5.3: Alterations in  HKII (A),  CS (B),  LDHA  (C), and PFKm  (D) mRNA 
abundances 3  h  after  a  single bout  of RES (grey  bars)  or  VRO (black bars) relative to 
baseline (white bars) levels. Bars and error  bars represent  mean  values and standard 
deviations, respectively. CS, citrate synthase;  HKII,  hexokinase II; LDHA, lactate 
dehydrogenase A; PFKm, phospho fructokinase, muscle type; RES, resistance 
exercise; VRO, Galileo®  vibration + resistance exercise + vascular occlusion.  ** 
significantly  different from  baseline,  P < 0.01; #  significantly  different within 
exercise modality RES vs. VRO, P < 0.05.
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Figure 5.4: Alterations in  XD (A) and MnSOD (B) mRNA  abundances 3  h  after  a 
single bout of RES (grey  bars)  or  VRO (black  bars) relative to baseline (white bars) 
levels. Bars and error  bars represent  mean  values and standard deviations, 
respectively.  MnSOD, manganese superoxide dismutase; RES,  resistance exercise; 
VRO, Galileo®  vibration + resistance exercise + vascular  occlusion; XD, xanthine 
dehydrogenase. * significantly  different  from  baseline,  P < 0.05; ## significantly 
different within exercise modality RES vs. VRO, P < 0.01.
Correlations between alterations in mRNA abundances
The increase of mRNA for  PGC-1α was positive correlated with  the increase of 
mRNA  for  VEGF (R2 = 0.653, P < 0.001, Fig. 5.5A) and MnSOD (R2 = 0.200, P = 
0.082, Fig. 5.5B) after RES and VRO.
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Figure 5.5: Increases of VEGF mRNA  (A)  and MnSOD mRNA  (B)  as a  function  of 
increases in  PGC-1α mRNA  abundance after  VRO and RES. MnSOD, manganese 
superoxide dismutase; PGC-1α,  peroxisome proliferator-activated receptor 
coactivator 1α; VEGF, vascular endothelial growth factor.
Discussion
The principal  finding  of the present  study  was that  two sets of VRO increased both 
the expression of PGC-1α and VEGF, in  contrast to RES alone.  Furthermore,  only 
VRO increased HKII, XD, and MnSOD mRNA abundances. These findings indicate 
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that  VRO activates gene programmes normally  associated with  endurance exercise 
and/or oxidative stress.
Three hours post-exercise,  VEGF and PGC-1α mRNA abundances were increased for 
VRO but not  RES (Fig.  5.1A, 5.2A),  indicating  that the superimposed stimuli  (i.e. 
whole-body  vibration  and vascular  occlusion)  mediated the increase in  VEGF and 
PGC-1α  expression. VEGF plays an  essential role in  exercise-induced angiogenesis in 
skeletal  muscle  (Olfert et al. 2010),  and a reduced oxygen partial pressure represents 
a  major  stimulus for  inducing  VEGF (Forsythe et  al.  1996). However,  it  remains 
inconclusive as to whether endurance exercise in  systemic hypoxia  or with  restricted 
blood flow  potentiates the VEGF response (Gustafsson  et al. 1999,  2002, Richardson 
1999).  Questioning the importance of a reduced cellular  partial oxygen  pressure as a 
stimulus for  an  exercise-induced increase in  VEGF expression  Richardson  et  al. 
(1999) suggested that  there  exists an  intracellular  oxygen  partial pressure 
“threshold”  beyond which  no greater  angiogenic  stimulus is produced, and that 
endurance exercise in  normoxia  can achieve this threshold. However, vascular 
occlusion was sustained after  exhaustive resistance exercise in VRO leading  to a 
sufficient stimulus to increase the VEGF expression. 
In  cell culture, it  has been shown that  hypoxia  increases the VEGF mRNA 
abundance through  transcription  factor  HIF-1  activated VEGF promoter  activity 
(Forsythe et  al.  1996). HIF-1  is a  heterodimeric  transcription  factor  composed of the 
HIF-1α and HIF-1β subunits and its activity  is post-translationally  regulated by 
HIF-1α stabilisation  in hypoxic  conditions. Similar  to hypoxia, endurance exercise 
has been  shown to induce VEGF mRNA  and HIF-1α protein  abundances (Ameln  et 
al.  2005,  Gustafsson et al. 1999). Notably,  HIF-1α mRNA  expression in human 
skeletal  muscles remains unaffected with  endurance exercise (Ameln  et al.  2005, 
Gustafsson et al. 1999).  VRO neither  increased HIF-1α mRNA  abundance nor the 
expression  of HIF-1α  target  genes (e.g.  PHD3, LDHA,  PFKa) (Fig.  5.2B, C, 5.3C, D), 
which  leads us to suggest that  VEGF expression  was induced in  a  HIF-1  independent 
manner. Nevertheless,  we cannot exclude that the increase in  VEGF expression  was 
driven by HIF-1α, since we did not assess HIF-1α protein content or activity. 
Instead of HIF-1α,  two other  possible mechanisms could explain why  VEGF was 
induced after  VRO but  not  RES: 1) increased PGC-1α and/or  2) shear  stress.  In  fact, 
we found a very strong correlation between PGC-1α and VEGF mRNA expression 
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(R2 = 0.653,  P < 0.001, Fig.  5.5A).  It  has been reported that PGC-1α regulates VEGF 
in  rodent skeletal muscles (Chinsomboon  et  al.  2009,  Geng et  al.  2010),  probably  in 
a  HIF-1α independent  way  (Arany  et  al. 2008). Recently, it has also been shown  that 
the acute  response of PGC-1α mRNA  to high-intensity  exercise depends on  exercise 
intensity  (Egan et al.  2010,  Nordsborg et al. 2010) and/or  muscle fibre activation 
pattern  (Godin  et  al.  2010),  indicating  that  high  power  output and increased 
metabolic  cell stress are  key  factors for  inducing  PGC-1α  expression.  Since PGC-1α 
expression  was increased after  VRO only, superimposed sustained vascular 
occlusion and whole-body  vibration  might  have triggered this response. In  fact, 
(sustained) vascular  occlusion further  increases metabolic  cell stress (e.g. 
accumulation  of metabolites and ions) and side-alternating  vibration  increases 
power  output. Since VRO and RES were both based on  high-intensity  resistance 
exercise at  70% of 1RM, leading  to a  complete motor  unit  recruitment of the leg 
muscles when  completed to exhaustion  (DeLuca  1996), it  seems unlikely  that  a 
diverse muscle fibre activation  pattern accounted for  the different PGC-1α 
expression after VRO and RES.
Concomitant to the increase in  PGC-1α expression,  we found that  MnSOD and XD 
mRNA  abundances were both  elevated solely  after  VRO,  which indicates the 
presence of oxidative stress (Fig.  5.4).  Since it has been  shown that PGC-1α 
signalling  is sensitive to ROS (Kang  et  al. 2009, St-Pierre et  al. 2006), we suspect 
that  the elevated oxidative stress after  VRO led to the observed increase in  PGC-1α 
expression. Consistent  with  this notion,  we found a  moderate but barely  not 
significant correlation  between PGC-1α  and MnSOD mRNA  expression  (R2 = 0.200, 
P = 0.082,  Fig.  5.5B).  The increase in  XD mRNA  after  VRO but  not  RES further 
highlights the specific roles of (sustained) vascular  occlusion  and vibration  in  the 
generation  of oxidative stress. XD is the dehydrogenase form  of xanthine oxidase 
(XO), which  is localised in  the vascular  walls of skeletal  muscles but not  in  the 
skeletal  muscle itself (Hellsten-Westing  1993).  This fact is highlighted by  the low  XD 
mRNA  copy  numbers (Fig.  5.4A).  XO is capable of producing  superoxide radicals 
(Vina  et  al.  2000) and has been  identified as a  source of superoxide in reperfusion 
injury. Thus,  it  can be speculated that similar  to reperfusion injury,  VRO led to the 
conversion  of XD to XO in  endothelial  cells of the vascular  walls, and subsequently 
to the production  of ROS,  which  in  turn  triggered the expression  of PGC-1α in 
skeletal  muscle  cells.  Alternatively  or  concomitantly,  VEGF expression  after  VRO 
might also have been driven by mechanical and shear stresses (Prior et al. 2004). In 
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this regard,  vibration  exercise has been  reported to induce shear  stress at  the wall of 
vessels leading  to increases in  circulating  blood VEGF protein  (Suhr  et al. 2007). 
Thus, based on  our  findings it  appears that both  sustained vascular  occlusion  and/or 
the associated reperfusion,  and whole body  vibration contributed to the induction  of 
VEGF mRNA abundance after VRO.
Although  PGC-1α expression  was significantly  increased after  VRO, ERRα,  NRF-1, 
and Tfam  remained unaffected (Fig.  5.2B, C, and D).  These findings are in  line with 
reports of other  studies in  humans,  where it  has also been  observed that despite the 
marked increase in  PGC-1α,  NRF1, and Tfam  remain  unaffected (Norrbom  et al. 
2004,  Pilegaard et  al.  2003). In contrast, in C2C12  myotubes overexpressing 
PGC-1α,  NRF1  and NRF2α mRNA are dramatically  increased (Wu  et  al.  1999). 
Moreover, HKII,  a gene that  is often associated with  adaptations to endurance 
training,  was only  up-regulated after  VRO (Fig.  5.3A), while other  metabolic key 
enzymes such as CS, LDHA, and PFKm  (Fig.  5.3B, C,  and D) were not  increased 
after  VRO or  RES. Pilegaard et  al.  (2003) also found that  HKII is the only  metabolic 
key  enzyme whose expression  is increased after  3  h  of knee extension exercise.  These 
authors suggested that genes display  a  different responsiveness to exercise and that 
there exists a  temporal hierarchy  to the transcriptional activation  of some genes 
after  a  single exercise stimulus. The fact  that the responses of these key  metabolic 
genes in the present study are in line with other investigations supports this concept. 
The herein  reported findings about  the molecular  changes after  an  acute bout  of 
VRO coincide with  the observed long-term  adaptations following repeated VRO 
exercise. Indeed, in Chapter 4 we have shown that 5 weeks of VRO training increases 
capillary-to-fibre ratio, skeletal  muscle oxidative  enzyme activity,  MYH-1  fibre 
proportion,  and endurance capacity.  Altogether,  these findings indicate that 
repeated VRO training mediates a  shift towards a  more oxidative and fatigue 
resistant muscle.  The results of this study  now  point  to a  major  role of PGC-1α and 
VEGF in  mediating  these cellular  adaptations. Of special note is,  that  these VRO-
induced changes at  the molecular,  cellular,  and functional levels are typically 
observed after  traditional endurance exercise or more recently  also after  sprint 
interval training  (Burgomaster  et  al.  2008,  Gibala  et al.  2009), but not  after 
resistance exercise. Our  findings support previous studies, which disclosed that not 
the duration of a specific exercise modality is most important for adaptations 
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leading  to an  oxidative skeletal  muscle fibre phenotype but rather  the degree of 
metabolic perturbation of the skeletal muscles.
In  summary,  we have reported that modified high-intensity  resistance exercise 
activates gene programmes typically  linked to endurance exercise. VRO increased 
the expression  of VEGF mRNA  through  ROS-activated PGC-1α and probably  in  a 
HIF-1α independent manner. Vascular  occlusion  and increased shear  stress 
probably  induced XO in endothelial cells of the vascular  walls, which  subsequently 
induced the production  of ROS. Whole-body  vibration  and (sustained)  vascular 
occlusion led to a  high metabolic cell  stress which  further accounts for  the presented 
molecular  responses.  These results indicate that  by  the addition  of specific stimuli to 
traditional exercise modalities the molecular  response and adaptations can be 
modified.
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Chapter 6
General discussion and outlook
The present thesis was aimed at providing  new  insights into the mechanisms 
underlying aerobic  function  and skeletal  muscle plasticity. In  order  to achieve our 
objectives, we established two methods (e.g.  electric  pulse stimulation  [EPS] cell 
culture system  and magnetic resonance-compatible ergometer  setup),  designed a 
new  exercise modality  (e.g side-alternating  whole body  vibration training with 
superimposed resistance exercise and vascular  occlusion [VRO]),  and performed 
four studies by using cell culture, rodent, and human models. 
Typically,  improvements in  aerobic function  result after  endurance exercise training, 
whereas an  impaired aerobic function  is related to physical  inactivity  and chronic 
diseases.  In chapter 2  of this thesis,  we provided substantial  evidence that oxidative 
capacity  and aerobic exercise performance in  young  untrained women  with  type 1 
diabetes are not  reduced compared to healthy  women of similar age and activity,  but 
that  in  women with  type 1  diabetes,  glycaemic status affects oxidative capacity. 
These findings reveal that  only  patients with  type 1  diabetes and high  HbA1c  (> 
7.6%) have a  reduced oxidative capacity  as compared to patients with  type 1  diabetes 
and low  HbA1c. However,  based on  the negative correlation  between  HbA1c  and 
oxidative capacity, it  is not clear  whether  there exist  a  causal connection. A  recent 
study  reported that  endurance athletes (following  an  endurance exercise training 
programme) with  type 1  diabetes and high  (> 7%) HbA1c have lower  peak oxygen 
consumption,  peak stroke volume, and peak cardiac  output  relative to athletes with 
low (< 7%) HbA1c, and that HbA1c negatively correlates with peak stroke volume
(Baldi et  al.  2010). Although  in  the study  of Baldi et  al. (2010) only  systemic factors 
affecting  aerobic function were analysed and not  oxidative capacity, these results 
support  our  findings that  glycaemic status makes a  major  impact  on  aerobic 
function.  The practical  relevance of these  findings is that in  order  to gain  health 
benefits,  patients with  type 1  diabetes are advised first to lower  their  glycaemic 
status,  and then second to improve their  aerobic  function by  regular  physical 
activity. Furthermore, it  is important to accurately  control  glycaemic  status in  future 
studies investigating  the aerobic  function  in  patients with  type 1  diabetes.  It is 
possible that  although  participants in  our  study  were untrained (less than  1  h  of 
physical  activity  per  week),  it  could be that the patients with  lower  HbA1c levels 
rather  follow  a  moderate physically  active life-style (e.g.  walking and cycling  instead 
of taking  public  transport  or  car,  using  the elevator),  whereas participants with 
higher  HbA1c  levels are entirely  physical inactive. If this is true, environmental/
lifestyle-related factors would account  for  the reduced oxidative capacity  rather  then 
the level of glycaemic control.  Nevertheless, based on  the fact  that we and Baldi et  al. 
(2010) accurately  controlled the physical  activity  behaviour of the study  participants 
it is very likely that glycaemic status makes a major impact on aerobic function.
We developed a  MR-compatible ergometer  setup which was comprised of a 
dynamometer  with  an integrated strain  gauge for  force measurements and a real-
time visual feedback system  for  providing the participants with  information  on  the 
level of exerted force relative to maximal voluntary  force.  The combination  of this 
ergometer setup with  31P-MRS allowed us to measure real-time skeletal muscle 
energetic  properties at  rest,  during,  and after  exercise. We propose to use this tool in 
future studies to analyse the oxidative capacity  of patients with  a broader  range of 
HbA1c levels and physical  activity  behaviour.  Then,  these studies should provide 
more information  about  the roles of physical activity  and aerobic  function  in  the 
aetiology  of diabetes.  A  further  approach to elucidate the molecular  and cellular 
mechanisms underlying  the relationship between  glycaemic status and aerobic 
function of the skeletal muscle is to use our  newly  developed in vitro  exercise 
system.  We established a cell  culture model using murine C2C12  myocytes that 
closely  recapitulates the plastic  changes in  gene expression as observed in 
aerobically  trained skeletal  muscle of mice (Chapter  3). Thus, we presented evidence 
that  EPS is a  valid tool to mimic exercise conditions in vitro.  In  future studies, our 
EPS system  can  be extended with  additional stimuli such  as mechanical stretch  and 
hypoxia. Furthermore, C2C12 myocytes could be replaced by mouse or human
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primary  myoblasts. By  using  primary  myoblasts from  donors with  low  or  high 
HbA1c levels instead of C2C12  myocytes, this system  would be an  elegant tool to 
investigate the molecular  and cellular  mechanism  underlying  the relationship 
between  glycaemic status and aerobic function of the skeletal muscle in  relation  to 
physical activity. 
To determine whether  it  is possible to improve aerobic function  in  humans with  an 
exercise modality  which  is based on  resistance exercise, we aimed at examining the 
effectiveness and efficiency  of VRO. We presented evidence that VRO training  led to 
a  more oxidative skeletal muscle phenotype (Chapter  4)  which  was additionally 
supported by  the finding that  a  single bout  of VRO activated gene programmes 
normally  associated with  endurance exercise (Chapter  5). As a  next  step,  the single 
stimuli of VRO need to be analysed in  order  to assign  a specific adaptation/effect  to 
a  specific  stimulus. However,  being aware of the very  short  time commitment  of 
VRO which  led to the relevant  adaptations/effects,  it  is likely  that the combination  of 
the different stimuli  rather  than  a  single stimulus was responsible for  the observed 
outcomes.  The substantial findings presented in  our  human  studies are in  line with 
recent  reports that not  only  traditional endurance exercise training leads to a  more 
oxidative skeletal muscle phenotype and an  associated improved endurance capacity 
but also high-intensity  cycling  and sprint  interval training (Burgomaster  et al.  2008, 
Egan et al.  2010, Gibala  et  al. 2009, Nordsborg  et  al.  2010). Our  results support the 
notion that  not  the duration  of a  specific exercise modality  is most  important  for 
adaptations leading to an oxidative skeletal muscle fibre phenotype but rather  the 
degree of metabolic perturbation of the skeletal muscles.  Our  in vitro  exercise 
system  could further  be useful to deepen  our  understanding  of the exact  molecular 
mechanism  underlying the adaptations to VRO. As VRO was comprised of vibration 
and resistance exercise with  superimposed vascular  occlusion,  these stimuli  are 
present  in  our  proposed in vitro  exercise system.  Thus, this system  would be a 
valuable tool  to investigate the single and additive effects of hypoxia, cyclic  stretch, 
and EPS and would serve as a valuable tool which complements our human studies.
As we initially  proposed, it  is fundamental  to identify  which  mechano-biological 
condition  leads to the molecular/cellular  response that is associated with  an 
oxidative gene programme, and how  this molecular/cellular  response relates to an 
improved aerobic function  (Chapter 1,  Toigo and Boutellier 2006).  The results 
presented in this thesis nicely illustrate that by addition of specific stimuli to
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traditional exercise  modalities (e.g.  endurance or  resistance exercise) the molecular 
response and adaptations can  be modified and thus be analysed. We demonstrated a 
possibility  for  future studies to investigate the importance of specific exercise 
stimuli. The future challenge is to fully  elucidate the contribution  of each  single 
exercise stimuli to the exercise-induced adaptations and effects.  With  this 
knowledge we will be able to design  new  effective therapeutic  exercise interventions 
for many of the chronic diseases.
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